Podcasts about american society

The ASAP Career Stages Framework is a data-driven resource for executive assistants and administrative professionals to identify skills gaps and map their career progression. Want something executives and HR will listen to and that will move the needle for your career advancement? This is it. Recorded at EA Ignite Spring 2025 and produced by the American Society of Administrative Professionals - ASAP. Learn more and submit a listener question at asaporg.com/podcast.

Botanical art and science truly feed off of one another. A good botanical artist must understand their subjects to do them justice which fosters a deeper understanding and appreciation for the plants, their habitats, and their role in ecosystems around the world. Join me and botanical artist Carol Woodin as we explore her love of botanical art and her role in helping the American Society of Botanical Artists connect people to plants. This episode was produced in part by Sanza, Eva, Yellowroot, Wisewren, Nadia, Heidi, Blake, Josh, Laure, R.J., Carly, Lucia, Dana, Sarah, Lauren, Strych Mind, Linda, Sylvan, Austin, Sarah, Ethan, Elle, Steve, Cassie, Chuck, Aaron, Gillian, Abi, Rich, Shad, Maddie, Owen, Linda, Alana, Sigma, Max, Richard, Maia, Rens, David, Robert, Thomas, Valerie, Joan, Mohsin Kazmi Photography, Cathy, Simon, Nick, Paul, Charis, EJ, Laura, Sung, NOK, Stephen, Heidi, Kristin, Luke, Sea, Shannon, Thomas, Will, Jamie, Waverly, Brent, Tanner, Rick, Kazys, Dorothy, Katherine, Emily, Theo, Nichole, Paul, Karen, Randi, Caelan, Tom, Don, Susan, Corbin, Keena, Robin, Peter, Whitney, Kenned, Margaret, Daniel, Karen, David, Earl, Jocelyn, Gary, Krysta, Elizabeth, Southern California Carnivorous Plant Enthusiasts, Pattypollinators, Peter, Judson, Ella, Alex, Dan, Pamela, Peter, Andrea, Nathan, Karyn, Michelle, Jillian, Chellie, Linda, Laura, Miz Holly, Christie, Carlos, Paleo Fern, Levi, Sylvia, Lanny, Ben, Lily, Craig, Sarah, Lor, Monika, Brandon, Jeremy, Suzanne, Kristina, Christine, Silas, Michael, Aristia, Felicidad, Lauren, Danielle, Allie, Jeffrey, Amanda, Tommy, Marcel, C Leigh, Karma, Shelby, Christopher, Alvin, Arek, Chellie, Dani, Paul, Dani, Tara, Elly, Colleen, Natalie, Nathan, Ario, Laura, Cari, Margaret, Mary, Connor, Nathan, Jan, Jerome, Brian, Azomonas, Ellie, University Greens, Joseph, Melody, Patricia, Matthew, Garrett, John, Ashley, Cathrine, Melvin, OrangeJulian, Porter, Jules, Griff, Joan, Megan, Marabeth, Les, Ali, Southside Plants, Keiko, Robert, Bryce, Wilma, Amanda, Helen, Mikey, Michelle, German, Joerg, Cathy, Tate, Steve, Kae, Carole, Mr. Keith Santner, Lynn, Aaron, Sara, Kenned, Brett, Jocelyn, Ethan, Sheryl, Runaway Goldfish, Ryan, Chris, Alana, Rachel, Joanna, Lori, Paul, Griff, Matthew, Bobby, Vaibhav, Steven, Joseph, Brandon, Liam, Hall, Jared, Brandon, Christina, Carly, Kazys, Stephen, Katherine, Manny, doeg, Daniel, Tim, Philip, Tim, Lisa, Brodie, Bendix, Irene, holly, Sara, and Margie.

Send us a textIn this episode of The AI Advantage, Matt Brown speaks with Saxon Knight, founding board member of the American Society for AI. They explore how U.S. leaders can approach AI adoption through both offense and defense, balancing innovation with regulation in an environment where Washington can't keep pace. Drawing lessons from America's cybersecurity past, Saxon explains why boards and executives need guardrails now, why building versus buying AI tools matters for U.S. enterprises, and how sectors like healthcare and legal could emerge as surprising leaders in the American AI landscape.Support the show

In this special episode of Unstoppable Mindset, I had the privilege of sitting down with the remarkable Ivan Cury—a man whose career has taken him from the golden days of radio to groundbreaking television and, ultimately, the classroom.   Ivan began acting at just four and a half years old, with a chance encounter at a movie theater igniting a lifelong passion for storytelling. By age eleven, he had already starred in a radio adaptation of Jack and the Beanstalk and went on to perform in classic programs like Let's Pretend and FBI in Peace and War. His talent for voices and dialects made him a favorite on the air.   Television brought new opportunities. Ivan started out as a makeup artist before climbing the ranks to director, working on culturally significant programs like Soul and Woman, and directing Men's Wearhouse commercials for nearly three decades. Ivan also made his mark in academia, teaching at Hunter College, Cal State LA, and UCLA. He's written textbooks and is now working on a book of short stories and reflections from his extraordinary life.   Our conversation touched on the importance of detail, adaptability, and collaboration—even with those we might not agree with. Ivan also shared his view that while hard work is crucial, luck plays a bigger role than most of us admit.   This episode is packed with insights, humor, and wisdom from a man who has lived a rich and varied life in media and education. Ivan's stories—whether about James Dean or old-time radio—are unforgettable.     About the Guest:   Ivan Cury began acting on Let's Pretend at the age of 11. Soon he was appearing on Cavalcade of America, Theatre Guild on the Air,  The Jack Benny Program, and many others.  Best known as Portia's son on Portia Faces Life and Bobby on Bobby Benson and The B-Bar-B Riders.    BFA: Carnegie Tech, MFA:Boston University.   Producer-director at NET & CBS.  Camera Three's 25th Anniversary of the Julliard String Quartet, The Harkness Ballet, Actor's Choice and Soul! as well as_, _The Doctors and The Young and the Restless. Numerous television commercials, notably for The Men's Wearhouse.   Taught at Hunter, Adelphi, and UCLA.  Tenured at Cal State University, Los Angeles.  Author of two books on Television Production, one of which is in its 5th edition.    Ways to connect with Ivan:       About the Host:   Michael Hingson is a New York Times best-selling author, international lecturer, and Chief Vision Officer for accessiBe. Michael, blind since birth, survived the 9/11 attacks with the help of his guide dog Roselle. This story is the subject of his best-selling book, Thunder Dog.   Michael gives over 100 presentations around the world each year speaking to influential groups such as Exxon Mobile, AT&T, Federal Express, Scripps College, Rutgers University, Children's Hospital, and the American Red Cross just to name a few. He is Ambassador for the National Braille Literacy Campaign for the National Federation of the Blind and also serves as Ambassador for the American Humane Association's 2012 Hero Dog Awards.   https://michaelhingson.com https://www.facebook.com/michael.hingson.author.speaker/ https://twitter.com/mhingson https://www.youtube.com/user/mhingson https://www.linkedin.com/in/michaelhingson/   accessiBe Links https://accessibe.com/ https://www.youtube.com/c/accessiBe https://www.linkedin.com/company/accessibe/mycompany/ https://www.facebook.com/accessibe/       Thanks for listening!   Thanks so much for listening to our podcast! If you enjoyed this episode and think that others could benefit from listening, please share it using the social media buttons on this page. Do you have some feedback or questions about this episode? Leave a comment in the section below!   Subscribe to the podcast   If you would like to get automatic updates of new podcast episodes, you can subscribe to the podcast on Apple Podcasts or Stitcher. You can subscribe in your favorite podcast app. You can also support our podcast through our tip jar https://tips.pinecast.com/jar/unstoppable-mindset .   Leave us an Apple Podcasts review   Ratings and reviews from our listeners are extremely valuable to us and greatly appreciated. They help our podcast rank higher on Apple Podcasts, which exposes our show to more awesome listeners like you. If you have a minute, please leave an honest review on Apple Podcasts.       Transcription Notes:   Michael Hingson ** 00:16 Access Cast and accessiBe Initiative presents Unstoppable Mindset. The podcast where inclusion, diversity and the unexpected meet. Hi, I'm Michael Hingson, Chief Vision Officer for accessiBe and the author of the number one New York Times bestselling book, Thunder dog, the story of a blind man, his guide dog and the triumph of trust. Thanks for joining me on my podcast as we explore our own blinding fears of inclusion unacceptance and our resistance to change. We will discover the idea that no matter the situation, or the people we encounter, our own fears, and prejudices often are our strongest barriers to moving forward. The unstoppable mindset podcast is sponsored by accessiBe, that's a c c e s s i capital B e. Visit www.accessibe.com to learn how you can make your website accessible for persons with disabilities. And to help make the internet fully inclusive by the year 2025. Glad you dropped by we're happy to meet you and to have you here with us.   Michael Hingson ** 01:20 Well, hi everyone, and welcome to another episode of unstoppable mindset where inclusion, diversity and the unexpected meet. And the fun thing is, most everything really deals with the unexpected. That is anything that doesn't have anything to do with diversity or inclusion. And our guest today, Ivan Cury, is certainly a person who's got lots of unexpected things, I am sure, and not a lot necessarily, dealing with the whole issue of disabilities, inclusion and diversity, necessarily, but we'll see. I want to tell you a little bit about Ivan, not a lot, because I want him to tell but as many of you know who listen to unstoppable mindset on a regular basis. I collect and have had as a hobby for many years old radio shows. And did a radio program for seven years, almost at UC Irvine when I was there on kuci, where every Sunday night we played old radio shows. And as it turns out, Ivan was in a number of those shows, such as, let's pretend, which is mostly a children's show. But I got to tell you, some of us adults listened and listened to it as well, as well as other programs. And we'll get into talking about some of those things. Ivan has a really great career. He's done a variety of different things, in acting. He's been in television commercials and and he is taught. He's done a lot of things that I think will be fun to talk about. So we'll get right to it. Ivan, I want to thank you for being here and welcome you to unstoppable mindset. Thanks. Thanks. Good to be here. Well, tell us a little bit about kind of the early Ivan growing up, if you will. Let's start with that. It's always good to start at the beginning, as it were,   Ivan Cury ** 03:04 well, it's sorry, it's a great, yes, it's a good place to start. About the time I was four and a half, that's a good time to start. I walked past the RKO 81st, street theater in New York, which is where we lived, and there was a princess in a in a castle kept in the front of this wonderful building that photographs all over the place. Later on, I was to realize that that Princess was really the cashier, but at the time, it was a princess in a small castle, and I loved the building and everything was in it. And thought at that time, that's what I'm going to do when I grow up. And the only thing that's kind of sad is it's Here I am, and I'm still liking that same thing all these years later, that's that's what I liked. And I do one thing or another, I wound up entertaining whenever there was a chance, which really meant just either singing a song or shaking myself around and pretending it was a dance or thinking it was a dance. And finally, wound up meeting someone who suggested I do a general audition at CBS long ago, when you could do those kinds of things I did and they I started reading when I was very young, because I really, because I want to read comics, you know, no big thing about that. And so when I could finally read comics, I wound up being able to read and doing it well. And did a general audition of CBS. They liked me. I had a different kind of voice from the other kids that were around at the time. And and so I began working and the most in my career, this was once, once you once they found a kid who had a different voice than the others, then you could always be the kid brother or the other brother. But it was clear that I wasn't a kid with a voice. I was the kid with the Butch boy. So who? Was who, and so I began to work. And I worked a lot in radio, and did lots and lots of shows, hundreds, 1000s,   Michael Hingson ** 05:07 you mentioned the comics. I remember when we moved to California, I was five, and I was tuning across the dial one Sunday morning and found KFI, which is, of course, a state a longtime station out here was a clear channel station. It was one of the few that was the only channel or only station on that frequency, and on Sunday morning, I was tuning across and I heard what sounded like somebody reading comics. But they weren't just reading the comics. They were dramatized. And it turns out it was a guy named David Starling who did other shows and when. So I got his name. But on that show, he was the funny paper man, and they read the LA Times comics, and every week they acted them out. So I was a devoted fan for many years, because I got to hear all of the comics from the times. And we actually subscribed to a different newspaper, so I got two sets of comics my brother or father read me the others. But it was fun reading and listening to the comics. And as I said, they dramatize them all, which was really cool.   Ivan Cury ** 06:14 Yeah, no doubt I was one day when I was in the studio, I was doing FBI and peace and war. I used to do that all the time, several it was a sponsored show. So it meant, I think you got $36 as opposed to $24 which was okay in those days. And my line was, gee, Dad, where's the lava soap. And I said that every week, gee, Dad, where's the lava soap. And I remember walking in the studio once and hearing the guy saying, Ah, this television ain't never gonna work. You can't use your imagination. And, yeah,   Michael Hingson ** 06:52 well, except you really don't use your imagination near especially now I find that everything is way too spelled out, so you don't get to use your imagination.   Ivan Cury ** 07:03 Radio required you to use your radio required you to use it. Yeah, and, and if you had a crayon book at the time, well, and you were 12 or No, no, much younger than that, then it was and that was what you did, and it was fun.   Michael Hingson ** 07:17 So what was the first radio program that you were   Ivan Cury ** 07:20 it was very peculiar, is it New Year's Eve, 19 four? No, I don't know. I'm not sure. Now, it was 47 or 48 I think it was 48 Yeah, I was 11, and it was New Year's Eve, and it was with Hank Severn, Ted Cott, and I did a Jack and the Beanstalk. It was recording for caravan records. It became the number one kids record. You know, I didn't, there was no he didn't get residuals or anything like that. And the next day I did, let's pretend. And then I didn't work for three months. And I think I cried myself to sleep every night after that, because I absolutely loved it. And, you know, there was nothing my parents could do about this, but I wanted, I wanted in. And about three months later, I finally got to do another show. Peculiarly. The next show I did was lead opposite Helen Hayes in a play called no room for Peter Pan. And I just looked it up. It was May. I looked it up and I lost it already. I think, I think I may know what it is. Stay tuned. No, now, nope, nope, nope, ah, so that's it was not. This was May 1949, wow. What was it? Well, yeah, and it was, it was a the director was a man named Lester O'Keefe, and I loved Barry Fitzgerald, and I find even at a very early age, I could do an Irish accent. And I've been in Ireland since then. I do did this, just sometimes with the people knowing that I was doing it and I was it was fine. Sometimes they didn't, and I could get it is, it is pretty Irish, I think, at any rate, he asked me father, who was born in Russia, if we spoke Gaelic at home, we didn't. And so I did the show, and it was fine. Then I did a lot of shows after that, because here was this 11 year old kid who could do all this kind of   Michael Hingson ** 09:24 stuff. So what was no room for Peter Pan about,   Ivan Cury ** 09:27 oh, it was about a midget, a midget who is a young man, a young boy who never grows up, and there's a mind. He becomes a circus performer, and he becomes a great star, and he comes back to his town, to his mother, and there's a mine disaster, and the only one who can save them is this little person, and the kid doesn't want to do it, and it's and there's a moment where Helen Hayes, who played the lead, explained about how important it is the to give up your image and be and be. Man, be a real man, and do the thing, right thing to do. And so that was the   Michael Hingson ** 10:04 story. What show was it on? What series?   Ivan Cury ** 10:07 Electric Theater, Electric Theater, Electric Theater with Ellen Hayes, okay,   Michael Hingson ** 10:10 I don't think I've heard that, but I'm going to find it.   Ivan Cury ** 10:14 Well, yes, there's that one. And almost very soon afterwards, I did another important part with Walter Hughes, Walter Hamden. And that was on cavalcade of America, Ah, okay. And that was called Footlights on the frontier. And it was about, Tom about Joseph Jefferson, and the theater of the time, where the young kid me meets Abraham Lincoln, Walter Houston, and he saves the company. Well, those are the first, first shows. Was downhill from there. Oh, I don't   Michael Hingson ** 10:50 know, but, but you you enjoyed it, and, of course, I loved it, yes, why?   Ivan Cury ** 11:00 I was very friendly with Richard lamparsky. I don't even remember him, but he wrote whatever became of series of books. Whatever became of him was did a lot, and we were chatting, and he said that one of the things he noticed is that people in theater, people in motion pictures, they all had a lot of nightmare stories to tell about people they'd work with. And radio actors did not have so much of that. And I believe that you came in, you got your script, you work with people you like, mostly, if you didn't, you'd see you'd lose, you know, you wouldn't see them again for another Yeah, you only had to deal with them for three or four hours, and that was in the studio. And after that, goodbye.   Michael Hingson ** 11:39 Yeah, what was your favorite show that you ever did?   Ivan Cury ** 11:42 And it seems to me, it's kind of almost impossible. Yeah, I don't know,   Michael Hingson ** 11:51 a lot of fun ones.   Ivan Cury ** 11:54 I'll tell you the thing about that that I found and I wrote about it, there are only five, four reasons really, for having a job. One of them is money, one of them is prestige. One of them is learning something, and the other is having fun. And if they don't have at least two, you ought to get out of it. And I just had a lot of fun. I really like doing it. I think that's one of the things that's that keeps you going now, so many of these old time radio conventions, which are part of my life now, at least Tom sometimes has to do with with working with some of the actors. It's like tennis. It's like a good tennis game. You you send out a line, and you don't know how it's going to come back and what they're going to do with it. And that's kind of fun.   Michael Hingson ** 12:43 Well, so while you were doing radio, and I understand you weren't necessarily doing it every day, but almost, well, almost. But you were also going to school. How did all that work out   Ivan Cury ** 12:53 there is, I went to Professional Children's School. I went to a lot of schools. I went to law schools only because mostly I would, I would fail geometry or algebra, and I'd have to take summer session, and I go to summer session and I'd get a film, and so I'd leave that that session of summer session and do the film and come back and then go to another one. So in all, I wound up to being in about seven or eight high schools. But the last two years was at Professional Children's School. Professional Children's School has been set up. It's one of a number of schools that are set up for professional children, particularly on the East Coast. Here, they usually bring somebody on the set. Their folks brought on set for it. Their professional school started really by Milton Berle, kids that go on the road, and they were doing terribly. Now in order to work as a child Lacher in New York and probably out here, you have to get permission from the mayor's office and permission from the American Society of Prevention of Cruelty to Children. And you needed permits to do it, and those both organizations required the schools to show to give good grades you were doing in school, so you had to keep up your grades, or they wouldn't give you a permit, and then you couldn't work. PCs did that by having correspondence. So if a kid was on the road doing a show out of town in Philadelphia or wherever, they were responsible for whatever that week's work was, and we were all we knew ahead of time what the work was going to be, what projects had to be sent into the school and they would be graded when I went, I went to Carnegie, and my first year of English, I went only, I think, three days a week, instead of five, because Tuesdays and Thursdays Were remedial. We wrote We were responsible for a term paper. Actually, every week, you we learned how to write. And it was, they were really very serious about it. They were good schools   Michael Hingson ** 14:52 well, and you, you clearly enjoyed it. And I know you also got very involved and interested in poetry as you went along. Too do. Yes, I did well, yeah, yeah. And who's your favorite poet?   Ivan Cury ** 15:07 Ah, my favorite poets. If that is hard to say, who my favorite is, but certainly they are more than one is Langston, Hughes, Mary, Oliver, wh Jordan, my favorite, one of my favorite poems is by Langston Hughes. I'll do it for you now. It's real easy. Burton is hard, and dying is mean. So get yourself some love, and in between, there you go. Yes, I love that. And Mary Oliver, Mary Oliver's memory, if I hope I do, I go down to the shore, and depending upon the hour, the waves are coming in and going out. And I said, Oh, I am so miserable. Watch. What should I do? And the sea, in its lovely voice, says, Excuse me, I have work to do.   Michael Hingson ** 15:56 Ooh. That puts it in perspective, doesn't   Ivan Cury ** 16:00 it? Yes, it certainly does.   Michael Hingson ** 16:03 So So you, you went to school and obviously had good enough grades that you were able to continue to to act and be in radio, yes, which was cool. And then television, because it was a television Lacher, yeah, yeah. It's beginning of television as well. So I know one of the shows that you were on was the Jack Benny show. What did you do for Jack? Oh, well,   Ivan Cury ** 16:28 I'm really stuffy. Singer is the guy who really did a lot of Jack Benny things. But what happened is that when Jack would come to New York, if there was a kid they needed, that was me, and so I did the Benny show, I don't know, two or three times when he was in New York. I, I did the Jack Benny show two or three times. But I was not so you were, you were nice, man. It came in. We did the show. I went   Michael Hingson ** 16:51 home. You were a part time Beaver, huh?   Ivan Cury ** 16:54 I don't know. I really don't know, but I was beaver or what? I don't remember anything other than I had been listening to the Jack Benny show as a kid. I knew he was a star and that he was a nice man, and when he came into the studio, he was just a nice man who who read Jack Benny's lines, and who was Jack Benny, and he said his lines, and I said my lines, and we had a nice time together. And there wasn't any, there wasn't any real interplay between us, other than what would be normal between any two human beings and and that was that. So I did the show, but I can't talk very much about Jack Benny.   Michael Hingson ** 17:32 Did you? Did you primarily read your scripts, or did you memorize them at all?   Ivan Cury ** 17:37 Oh, no, no, radio. That was the thing about radio. Radio that was sort of the joy you read. It was all about reading. It's all about reading, yeah. And one of the things about that, that that was just that I feel lucky about, is that I can pretty well look at a script and read it. Usually read it pretty well with before the first time I've ever seen it, and that's cold reading, and I was pretty good at that, and still am.   Michael Hingson ** 18:06 Did you find that as you were doing scripts and so on, though, and reading them, that that changed much when you went in into television and started doing television?   Ivan Cury ** 18:22 I don't know what you mean by change.   Michael Hingson ** 18:24 Did you you still read scripts and   Ivan Cury ** 18:26 yeah, no, no, the way. I mean the way intelligent show usually goes as an actor. Well, when I directed television, I used to direct a lot of soap operas, not a lot, but I directed soap operas, but there'd be a week's rehearsal for a show, danger, I'm syndicated, or anything, and so there'd be a week's rehearsal. The first thing you do is, we have a sit down read, so you don't read the script, and then you holding the script in your hand walk through the scenes. Sometimes the director would have, would have blocking that they knew you were going to they were going to do, and they say, here's what you do. You walk in the door, etc. Sometimes they say, Well, go ahead, just show me what you'd like, what you what it feels like. And from that blocking is derived. And then you go home and you try to memorize the lines, and you feel perfectly comfortable that as you go, when you leave and you come back the next day and discover you got the first line down. But from there on, it's dreadful. But after a while, you get into the thing and you know your lines. You do it. Soap opera. Do that.   Michael Hingson ** 19:38 The interesting thing about doing radio, was everything, pretty much, was live. Was that something that caused a lot of pressure for you?   Ivan Cury ** 19:51 In some ways, yes, and in some ways it's lovely. The pressure is, yes, you want to get it right, but if you got to get it but if you get it wrong, give it up, because it's all over. Uh, and that's something that's that isn't so if you've recorded it, then you start figuring, well, what can I do? How can I fix this? You know, live, you do it and it's done. That's, that's what it is, moving right along. And this, this comment, gets to be kind of comfortable, you know, that you're going to, there may be some mistakes. You do the best you can with it, and go on one of the things that's really the news that that happens, the news, you know, every night, and with all the other shows that are live every day,   Michael Hingson ** 20:26 one of the things that I've noticed in a number of radio shows, there are times that it's fairly obvious that somebody made a flub of some sort, but they integrated it in, and they were able to adapt and react, and it just became part of the show. And sometimes it became a funny thing, but a lot of times they just worked it in, because people knew how to do that. And I'm not sure that that is so much the case certainly today on television, because in reality, you get to do it over and over, and they'll edit films and all that. And so you don't have that, that same sort of thing, but some of those challenges and flubs that did occur on radio were really like in the Jack Benny shows and burns and Allen and Phil Harris and so on. They were, they just became integrated in and they they became classic events, even though they weren't necessarily originally part of the plan.   Ivan Cury ** 21:25 Absolutely, some of some of them, I suspect some of them, were planned and planned to sound as if they would just happen. But certainly mistakes. Gosh, good mistakes are wonderful. Yeah, in all kinds of I used to do a lot of live television, and even if we weren't live television, when we would just do something and we were going to tape it and do it later, I remember once the camera kind of going wrong, video going wrong. I went, Wait a minute. That's great. Let's keep it wrong like that, you know. And it was so is just lovely that that's part of the art of improvisation, with how   Michael Hingson ** 22:06 and and I think there was a lot more of that, certainly in radio, than there is on television today, because very few things are really live in the same   Ivan Cury ** 22:17 sense. No, there. There are some kinds of having written, there are some type formats that are live. The news is live, the news is live. There's no, you know, there are. There used to be, and there may still be some of the afternoon shows, the kind of morning and afternoon shows where Show and Tell Dr whatever his name is, Dr Phil, yeah, it may be live, or it's shot as live, and they don't, they don't really have a budget to edit, so it's got to be real bad before they edit. Yeah. So do a show like that called Woman of CBS. So there are shows that are live, like that, sport events are live. A lot of from Kennedy Center is live. There are, there are lots of programs that are live, concerts, that are that you are a lot of them. America's Got Talent might as well be live. So there's a lot of that. And certainly things go wrong in the ad lib, and that's the way, because, in fact, there's some lovely things that happen out of that, but mostly, you're absolutely right. Mostly you do show it's recorded. You intend to edit it, you plan it to be edited, and you do it. It's also different when you shoot multiple camera, as opposed to single camera, yeah, single camera being as you say, again and again and again, multiple camera, not so much, although I used to direct the young and the restless, and now there is a line cut which is almost never used. It's it's the intention, but every shot is isolated and then cleaned up so that it's whatever is, whatever is possibly wrong with it gets clean.   Michael Hingson ** 24:03 Yeah, it's, it's a sign of the changing times and how things, everything   Ivan Cury ** 24:09 is bad. It's just, it's different. In fact, that's a kind of question I'm really puzzled with right now for the fun of it. And that is about AI, is it good or bad?   Michael Hingson ** 24:20 Well, and it's like anything else, of course, it depends. One of the one of my, my favorite, one of my favorite things about AI is a few years, a couple of years ago, I was at a Christmas party when there was somebody there who was complaining about the fact that kids were writing their papers using AI,   Ivan Cury ** 24:43 and that's bad   Michael Hingson ** 24:44 and and although people have worked on trying to be able to detect AI, the reality is that this person was complaining that the kids were even doing it. And I didn't think about it until later, but I realized. Is one of the greatest blessings of AI is let the students create their papers using AI. What the teachers need to do is to get more creative. And by that I mean All right, so when children turn in and students turn in their papers, then take a day and let every student take about a minute and come up and defend the paper they wrote. You're going to find out really quickly who really knew the subject and who just let ai do it and didn't have any interaction with it. But what a great way to learn. You're going to find out very quickly. And kids are going to figure out very quickly that they need to really know the subject, because they're going to have to defend their   Ivan Cury ** 25:41 papers. Yeah, no, I think that's fine. I I don't like the amount of electricity that it requires and what it's doing to our to our needs for water, because it has to be cooled down. So there's some physical things that I don't like about AI, and I think it's like when you used to have to go into a test with a slide rule, and they you couldn't use your calculator. When I use a calculator, it's out of the bag. You can't put it back anymore. It's a part of our life, and how to use it is the question. And I think you're absolutely right. I don't even need to know whether. I'm not even sure you need to check the kids if they it. How will you use? How will we get to use? Ai, it is with us.   Michael Hingson ** 26:30 Well, but I think there's a the value of of checking and testing. Why I'm with you. I don't think it's wrong. I think, no, no, but I think the value is that it's going to make them really learn the subject. I've written articles, and I've used AI to write articles, and I will look at them. I'll actually have a create, like, eight or nine different versions, and I will decide what I like out of each of them, and then I will add my part to it, because I have to make it me, and I've always realized that. So I know anything that I write, I can absolutely defend, because I'm very integrally involved in what I do with it, although AI has come up with some very clever ideas. Yeah, I hadn't thought of but I still add value to it, and I think that's what's really important.   Ivan Cury ** 27:19 I did a I've been writing stuff for a while, and one of the things I did, I wrote this. I wrote a little piece. And I thought, well, what? What would ai do if they took the same piece? How would they do it? So I put it in and said, rewrite it. They did. It was kind of bland. They'd taken all the life out of it. It wasn't very Yeah. So then I said, Well, wait a minute, do the same thing, write it as if it were written by Damon Runyon. And so they took it and they did that, and it was way over the top and really ugly, but it I kind of had fun with what, what the potential was, and how you might want to use it. I mean, I think the way you using it is exactly right. Yeah, it's how you use it, when, when you when, I'm just as curious, when you do that, when you said, you write something, and you ask them to do it four or five times or many times. How do you how do you require them to do it differently.   Michael Hingson ** 28:23 Well, there are a couple different ways. One is, there are several different models that can use to generate the solution. But even leaving aside such as, Oh, let's see, one is, you go out and do more web research before you actually do the do the writing. And so that's one thing and another. I'm trying to remember there were, like, six models that I found on one thing that I did yesterday, and but, but the other part about it is that with AI, yeah, the other thing about AI is that you can just tell it you don't like the response that you   Ivan Cury ** 29:09 got. Aha, okay, all right, yep,   Michael Hingson ** 29:13 I got it. And when you do that, it will create a different response, which is one of the things that you want. So, so so that works out pretty well. And what I did on something, I wanted to write a letter yesterday, and I actually had it write it. I actually had it do it several times. And one time I told it to look at the web to help generate more information, which was pretty cool, but, but the reality is that, again, I also think that I need to be a part of the the solution. So I had to put my my comments into it as well, and, and that worked out pretty well. Okay, right? Yeah, so I mean, it's cool, and it worked. Right? And so the bottom line is we we got a solution, but I think that AI is a tool that we can use, and if we use it right, it will enhance us. And it's something that we all have to choose how we're going to do. There's no no come, yeah, no question about that. So tell me you were successful as a young actor. So what kind of what what advice or what kind of thoughts do you have about youth success, and what's your takeaway from that?   Ivan Cury ** 30:36 The Good, yeah, I There are a lot of things being wanting to do it, and I really love doing it, I certainly didn't want to. I wanted to do it as the best way I could Well, I didn't want to lose it up, is what it really comes down to. And that meant figuring out what it is that required. And one of the things that required was a sense of responsibility. You had to be there on time, you had to be on stage, and you may want to fidget, but that takes to distract from what's going on, so sit still. So there's a kind of kind of responsibility that that you learn, that I learned, I think early on, that was, that's very useful. Yeah, that's, that's really, I think that's, I wrote some things that I had, I figured, some of these questions that might be around. So there, there's some I took notes about it. Well, oh, attention to details. Yeah, to be care to be watch out for details. And a lot of the things can be carried on into later life, things about detailed, things about date. Put a date on, on papers. When, when did, when was this? No, when was this note? What? When did this happen? Just keeping track of things. I still am sort of astonished at how, how little things add up, how we just just noted every day. And at the end of a year, you've made 365 notes,   Michael Hingson ** 32:14 yeah, well, and then when you go back and read them, which is also part of the issue, is that you got to go back and look at them to to see what   Ivan Cury ** 32:23 right or to just know that they're there so that you can refer to them. When did that happen?   Michael Hingson ** 32:28 Oh, right. And what did you say? You know, that's the point. Is that when I started writing thunder dog, my first book was suggested that I should start it, and I started writing it, what I started doing was creating notes. I actually had something like 1.2 megabytes of notes by the time we actually got around to doing the book. And it was actually eight years after I started doing some, well, seven years after I started doing writing on it. But the point is that I had the information, and I constantly referred back to it, and I even today, when I deliver a speech, I like to if there's a possibility of having it recorded, I like to go back and listen, because I want to make sure that I'm not changing things I shouldn't change and or I want to make sure that I'm really communicating with the audience, because I believe that my job is to talk with an audience, not to an audience.   Ivan Cury ** 33:24 Yeah, yeah. I we say that I'm reading. There are three books I'm reading right now, one of them, one of them, the two of them are very well, it doesn't matter. One is called who ate the oyster? Who ate the first oyster? And it's a it's really about paleon. Paleological. I'm saying the word wrong, and I'm paleontological. Paleontological, yeah, study of a lot of firsts, and it's a lovely but the other one is called shady characters by Keith Houston, and it's a secret life of punctuation symbols and other typographical marks, and I am astonished at the number of of notes that go along with it. Probably 100 100 pages of footnotes to all of the things that that are a part of how these words came to be. And they're all, I'm not looking at the footnotes, because there's just too many, but it's kind of terrific to check out. To be that clear about where did this idea come from, where did this statement come from? I'm pleased about that. I asked my wife recently if you could be anything you want other than what you are. What would you want to be? What other what other job or would you want to have? The first one that came to mind for me, which I was surprised that was a librarian. I just like the detail. I think that's   Michael Hingson ** 34:56 doesn't go anywhere. There you go. Well, but there's so. There's a lot of detail, and you get to be involved with so many different kinds of subjects, and you never know what people are going to ask you on any given day. So there's a lot of challenge and fun to that.   Ivan Cury ** 35:11 Well, to me also just putting things in order, I was so surprised to discover that in the Dewey Decimal System, the theater is 812 and right next to it, the thing that's right next to it is poetry. I was surprised. It's interesting, yeah, the library and play that out.   Michael Hingson ** 35:29 Well, you were talking about punctuation. Immediately I thought of EE Cummings. I'll bet he didn't pay much attention to punctuation at all. I love him. He's great, yeah, isn't he? Yeah, it's a lot of fun. An interesting character by any standard. So, so you, you progressed into television, if, I guess it's progressing well, like, if we answer to Fred Allen, it's not, but that's okay.   Ivan Cury ** 35:54 Well, what happens? You know, after, after, I became 18, and is an interesting moment in my life, where they were going to do film with Jimmy Dean, James Dean, James Dean. And it came down and he was going to have a sidekick, a kid sidekick. And it came down to me and Sal Mineo. And Sal got it, by the way. Case you didn't know, but one of the things was I was asked I remember at Columbia what I wanted to do, and I said I wanted to go to college, and my there was a kind of like, oh, yeah, right. Well, then you're not going to go to this thing, because we don't. We want you to be in Hollywood doing the things. And yes, and I did go to college, which is kind of great. So what happened was, after, when I became 18, I went to Carnegie tech and studied theater arts. Then I after that, I studied at Boston University and got a master's there, so that I had an academic, an academic part of my life as well, right? Which ran out well, because in my later years, I became a professor and wrote some   Michael Hingson ** 36:56 books, and that was your USC, right? No, Cal State, Lacher State, LA and UCLA. And UCLA, not USC. Oh, shame on me. But that's my wife. Was a USC graduate, so I've always had loyalty. There you go. But I went to UC Irvine, so you know, okay, both systems, whatever.   Ivan Cury ** 37:16 Well, you know, they're both UC system, and that's different, yeah, the research institutes, as opposed to the Cal State, which   Michael Hingson ** 37:23 are more teaching oriented, yeah,   Ivan Cury ** 37:26 wow, yeah, that's, that's what it says there in the paper.   Michael Hingson ** 37:30 Yes, that's what it says. But you know, so you went into television. So what did you mainly do in the in the TV world?   Ivan Cury ** 37:44 Well, when I got out of when I got through school, I got through the army, I came back to New York, and I, oh, I got a job versus the Girl Scouts, doing public relations. I I taught at Hunter College for a year. Taught speech. One of the required courses at Carnegie is voice and diction, and it's a really good course. So I taught speech at Hunter College, and a friend of mine was the second alternate maker man at Channel 13 in New York. He had opera tickets, so he said, Look standard for me, it's easy, men seven and women five, and telling women to put on their own lipstick. So I did. I did that, and I became then he couldn't do it anymore, so I became the second alternate make a man. Then it didn't matter. Within within six months, I was in charge of makeup for any t which I could do, and I was able to kind of get away with it. And I did some pretty good stuff, some prosthetic pieces, and it was okay, but I really didn't want to do that. I wanted to direct, if I could. And so then I they, they knew that, and I they knew that I was going to leave if, if, because I wasn't going to be a makeup I didn't. So I became a stage manager, and then an associate director, and then a director at Channel 13 in New York. And I directed a lot of actors, choice the biggest show I did there, or the one that Well, I did a lot of I also worked with a great guy named Kirk Browning, who did the a lot of the NBC operas, and who did all of the opera stuff in for any t and then I wound up doing a show called Soul, which was a black variety show. But when I say black variety show, it was with James Baldwin and but by the OJS and the unifics and the delphonics and Maya Angelou and, you know, so it was a black culture show, and I was the only white guy except the camera crew there. But had a really terrific time. Left there and went and directed for CBS. I did camera three. So I did things like the 25th anniversary of the Juilliard stringer check. Quartet. But I was also directing a show called woman, which was one of the earliest feminist programs, where I was the only male and an all female show. And actually I left and became the only gringo on an all Latino show called aqui I ahora. So I had a strange career in television as a director, and then did a lot of commercials for about 27 years, I directed or worked on the Men's Warehouse commercials. Those are the facts. I guarantee it.   Michael Hingson ** 40:31 Did you get to meet George Zimmer? Oh, very, very, very often, 27 years worth, I would figure, yeah.   Ivan Cury ** 40:39 I mean, what? I'm enemies. When I met him, he's a boy, a mere boy.   Michael Hingson ** 40:45 Did you act during any of this time? Or were you no no behind the camera once?   Ivan Cury ** 40:50 Well, the only, the only acting I did was occasionally. I would go now in a store near you, got it, and I had this voice that they decided, Ivan, we don't want you to do it anymore. It just sounds too much like we want, let George do this, please.   Michael Hingson ** 41:04 So, so you didn't get to do much, saying of things like, But wait, there's more, right?   Ivan Cury ** 41:10 No, not at all. Okay, okay. Oh, but you do that very well. Let's try.   Michael Hingson ** 41:13 Wait, there's more, okay. Well, that's cool. Well, that was,   Ivan Cury ** 41:18 it was kind of fun, and it was kind of fun, but they had to, it was kind of fun to figure out things. I remember we did. We had a thing where some of those commercial we did some commercials, and this is the thing, I sort of figured out customers would call in. So we recorded their, their call ins, and I they, we said, with calls being recorded. We took the call ins and I had them sent to it a typist who typed up what they wrote that was sent to New York to an advertising agency would extract, would extract questions or remarks that people had made about the stuff, the remarks, the tapes would be then sent to who did that? I think we edited the tapes to make it into a commercial, but the tags needed to be done by an announcer who said, in a store near you were opening sooner, right? Wyoming, and so those the announcer for the Men's Warehouse was a guy in in Houston. So we'd send, we'd send that thing to him, and he'd send us back a digital package with the with the tags. And the fun of it was that was, it was from, the calls are from all over the world. The the edits on paper were done in New York, the physical work was done in San Francisco. The announcer was in Houston. And, you know? And it's just kind of fun to be able to do that, that to see, particularly having come from, having come from 1949 Yeah, where that would have been unheard of to kind of have that access to all that was just fun, kind   Michael Hingson ** 42:56 of fun. But think about it now, of course, where we have so much with the internet and so on, it'd be so much easier, in a lot of ways, to just have everyone meet on the same network and   Ivan Cury ** 43:09 do now it's now, it's nothing. I mean, now it's just, that's the way it is. Come on.   Michael Hingson ** 43:13 Yeah, exactly. So. So you know, one of the things that I've been thinking about is that, yes, we've gone from radio to television and a whole new media and so on. But at the same time, I'm seeing a fairly decent resurgence of people becoming fascinated with radio and old radio and listening to the old programs. Do you see that?   Ivan Cury ** 43:41 Well, I, I wish I did. I don't my, my take on it. It comes strictly from that such, so anecdotal. It's like, in my grandkids, I have these shows that I've done, and it's, you know, it's grandpa, and here it is, and there it's the bobby Benson show, or it's calculator America, whatever, 30 seconds. That's what they give me. Yeah, then it's like, Thanks, grandpa. Whoopie. I don't know. I think maybe there may there may be something, but I would, I'd want some statistical evidence about well, but   Michael Hingson ** 44:19 one of the things I'm thinking of when I talk about the resurgence, is that we're now starting to see places like radio enthusiasts to Puget Sound reps doing recreations of, oh yes, Carl Omari has done the Twilight Zone radio shows. You know, there are some things that are happening, but reps among others, and spurred back to some degree, yeah, spurred back is, is the Society for the Prevention, oh, gosh,   Ivan Cury ** 44:46 not cruelty children, although enrichment   Michael Hingson ** 44:49 of radio   Ivan Cury ** 44:50 drama and comedy, right? Society, right? Yeah, and reps is regional enthusiasts of Puget Sound, Puget   Michael Hingson ** 44:58 Sound and. Reps does several recreations a year. In fact, there's one coming up in September. Are you going to   Ivan Cury ** 45:04 that? Yes, I am. I'm supposed to be. Yes, I think I Yes. I am.   Michael Hingson ** 45:08 Who you're going to play? I have no idea. Oh, you don't know yet.   Ivan Cury ** 45:12 Oh, no, no, that's fun. You get there, I think they're going to have me do a Sam Spade. There is another organization up there called the American radio theater, right? And I like something. I love those people. And so they did a lot of Sam Spade. And so I expect I'm going to be doing a Sam Spade, which I look forward to.   Michael Hingson ** 45:32 I was originally going to it to a reps event. I'm not going to be able to this time because somebody has hired me to come and speak and what I was going to do, and we've postponed it until I can, can be the one to do it is Richard diamond private detective, which is about my most favorite radio show. So I'm actually going to play, able to play Richard diamond. Oh, how great. Oh, that'll be a lot of fun. Yeah. So it'll probably be next year at this point now, but it but it will happen.   Ivan Cury ** 45:59 I think this may, yeah, go ahead. This may be my last, my last show I'm getting it's getting tough to travel.   Michael Hingson ** 46:07 Yeah, yeah, I don't know. Let's see. Let's see what happens. But, but it is fun, and I've met several people through their Carolyn Grimes, of course, who played Zuzu on It's A Wonderful Life. And in fact, we're going to have her on unstoppable mindset in the not too distant future, which is great, but I've met her and and other people, which I   Ivan Cury ** 46:34 think that's part of the for me. That really is part of the fun. Yeah, you become for me now it has become almost a sec, a family, in the same way that when you do show, if you do a show regularly, it is, it really becomes a family. And when the show is over, it's that was, I mean, one of the first things as a kid that was, that was really kind of tough for every day, or every other day I would meet the folks of Bobby Benson and the B Barbie writers. And then I stopped doing the show, and I didn't see them and didn't see them again. You know, I Don Knotts took me to I had the first shrimp of my life. Don Knotts took me to take tough and Eddie's in New York. Then I did another show called paciolini, which was a kind of Italian version of The Goldbergs. And that was, I was part of that family, and then that kind of went away. I was Porsche son on Porsche faces life, and then that way, so the you have these families and they and then you lose them, but, but by going to these old events, there is that sense of family, and there are also, what is just astonishing to me is all those people who know who knows stuff. One day I mentioned Frank Milano. Now, nobody who knows Frank Milano. These guys knew them. Oh, Frank, yeah, he did. Frank Milano was a sound. Was did animal sounds. There were two guys who did animal sounds particularly well. One was Donald Baines, who I worked with on the first day I ever did anything. He played the cow on Jack and the Beanstalk and and Frank, Don had, Don had a wonderful bar room bet, and that was that he could do the sound effects of a fish. Wow. And what is the sound effect of a fish? So now you gotta be required. Here's the sound effect of a fish. This was what he went $5 bets with you. Ready? Here we go.   Michael Hingson ** 48:41 Good job. Yeah, good job. Yeah. It's like, what was it on? Was it Jack Benny? They had a kangaroo, and I think it was Mel Blanc was asked to do the kangaroo, which is, of course, another one where they're not really a sound, but you have to come up with a sound to do it on radio, right?   Ivan Cury ** 49:06 Yes. Oh my god, there were people who want I could do dialects, I could do lots of German film, and I could do the harness. Was very easy for me to do, yeah, so I did love and I got to lots of jobs because I was a kid and I could do all these accents. There was a woman named Brianna Rayburn. And I used to do a lot of shows in National Association of churches of Christ in the United States. And the guy who was the director, John Gunn, we got to know each other. He was talking about, we talked with dialects. He said Briana Rayburn had come in. She was to play a Chinese woman. And she really asked him, seriously, what part of China Do you want her to come from? Oh, wow. I thought that was just super. And she was serious. She difference, which is studied, studied dialects in in. In college not long after, I could do them, and discovered that there were many, many English accents. I knew two or three cockney I could do, but there were lots of them that could be done. And we had the most fun. We had a German scholar from Germany, from Germany, and we asked him if he was doing speaking German, but doing playing the part of an American what would it sound like speaking German with an American accent? You know, it was really weird.   Michael Hingson ** 50:31 I had a history teacher, yes, who was from the Bronx, who spoke German, yeah, and he fought in World War Two. And in fact, he was on guard duty one night, and somebody took a shot at him, and so he yelled back at them in German. The accent was, you know, I took German, so I don't understand it all that well, but, but listening to him with with a New York accent, speaking German was really quite a treat. The accent spilled through, but, but they didn't shoot at him anymore. So I think he said something, what are you shooting at me for? Knock it off. But it was so funny, yeah, but they didn't shoot at him anymore because he spoke, yeah, yeah. It was kind of cool. Well, so with all that you've learned, what kind of career events have have sort of filtered over into what you do today?   Ivan Cury ** 51:28 Oh, I don't know. We, you know. But one of the things I wanted to say, it was one of the things that I learned along the way, which is not really answering your question until I get back to it, was, I think one of those best things I learned was that, however important it is that that you like someone, or you're with somebody and everything is really terrific. One of the significant things that I wish I'd learned earlier, and I think is really important, is how do you get along when you don't agree? And I think that's really very important.   Michael Hingson ** 52:01 Oh, it's so important. And we, in today's society, it's especially important because no one can tolerate anyone anymore if they disagree with them, they're you're wrong, and that's all there is to it. And that just is so unfortunate. There's no There's no really looking at alternatives, and that is so scary   Ivan Cury ** 52:20 that may not be an alternative. It may not be,   Michael Hingson ** 52:23 but if somebody thinks there is, you should at least respect the opinion,   Ivan Cury ** 52:28 whatever it is, how do you get along with the people you don't   Michael Hingson ** 52:32 agree with? Right?   Ivan Cury ** 52:35 And you should one that you love that you don't agree with, right? This may sound strange, but my wife and I do not agree about everything all the time, right?   Michael Hingson ** 52:43 What a concept. My wife and I didn't agree about everything all the time. Really, that's amazing, and it's okay, you know? And in fact, we both one of the the neat things, I would say, is we both learned so much from each other when we disagreed, but would talk about it, and we did a lot of talking and communicating, which I always felt was one of the most important things about our marriage. So we did, we learned a lot, and we knew how to get along, and we knew that if we disagreed, it was okay, because even if we didn't change each other's opinion, we didn't need to try to change each other's opinion, but if we work together and learn to respect the other opinion, that's what really mattered, and you learn more about the individual that way,   Ivan Cury ** 53:30 yeah, and also you have you learn about giving up. Okay, I think you're wrong, but if that's really what you want exactly, I'll do it. We'll do it your way?   Michael Hingson ** 53:42 Yeah, well, exactly. And I think it's so important that we really put some of that into perspective, and it's so crucial to do that, but there's so much disagreement today, and nobody wants to talk to anybody. You're wrong. I'm right. That's all there is to it. Forget it, and that's just not the way the world should be.   Ivan Cury ** 53:59 No, no. I wanted to go on to something that you had asked about, what I think you asked about, what's now I have been writing. I have been writing to a friend who I've been writing a lot of very short pieces, to a friend who had a stroke and who doesn't we can't meet as much as we use. We can't meet at all right now. And but I wanted to just go on, I'm and I said that I've done something really every week, and I'd like to put some of these things together into a book. And what I've been doing, looking for really is someone to work with. And so I keep writing the things, the thing that I wrote just today, this recent one, had to do with I was thinking about this podcast. Is what made me think of it. I thought about the stars that I had worked with, you know, me and the stars, because I had lots. Stories with with people who are considered stars, Charles Lawton, Don Knotts, Gene crane, Maya, Angelou, Robert Kennedy, the one I wrote about today. I wrote about two people. I thought it'd be fun to put them together, James Dean and Jimmy Dean. James Dean, just going to tell you the stories about them, because it's the kind of thing I'm writing about now. James Dean, we worked together on a show called Crime syndicated. He had just become really hot in New York, and we did this show where there were a bunch of probably every teenage actor in New York was doing this show. We were playing two gangs, and Jimmy had an extraordinary amount of lines. And we said, What the hell are you going to do, Jim? If you, you know, if you lose lines, he's, this is live. And he said, No problem. And then what he said is, all I do is I start talking, and then I just move my mouth like I'm walking talking, and everybody will think the audio went out. Oh, and that's, that's what he was planning on doing. I don't know if he really is going to do it. He was perfect. You know, he's just wonderful. He did his show. The show was great. We were all astonished to be working with some not astonished, but really glad to just watch him work, because he was just so very good. And we had a job. And then stories with Jimmy Dean. There were a couple of stories with Jimmy Dean, the singer and the guy of sausage, right? The last one to make it as fast, the last one was, we were in Nashville, at the Grand Ole Opry Opperman hotel. I was doing a show with him, and I was sitting in the bar, the producer and someone other people, and there was a regular Graceland has a regular kind of bar. It's a small bar of chatter, cash register, husband, wife, team on the stage singing. And suddenly, as we were talking, it started to get very quiet. And what had happened is Jimmy Dean had come into the room. He had got taken the guitar, and he started to sing, and suddenly it just got quiet, very quiet in the room. The Register didn't ring. He sang one song and he sang another song. His applause. He said, Thank you. Gave the guitar back to the couple. Walked off the stage. It was quiet while a couple started to sing again. They were good. He started to sing. People began to chatter again. The cash register rang, and I, I certainly have no idea how he managed to command that room to have everybody shut up while he sang and listened to him. He didn't do anything. There was nothing, you know, no announcement. It wasn't like, oh, look, there's Jimmy. It was just his, his performance. It was great, and I was really glad to be working with him the next day well.   Michael Hingson ** 57:56 And I think that having that kind of command and also being unassuming about it is pretty important if you've got an ego and you think you're the greatest thing, and that's all there is to it. That shows too, yeah?   Ivan Cury ** 58:08 Well, some people live on it, on that ego, yeah, and I'm successful on it, I don't think that was what. It certainly   Michael Hingson ** 58:17 wasn't, no, no, no, and I'm not saying that. I'm sure it wasn't that's my point. Yeah, no, because I think that the ultimate best people are the ones who don't do it with ego or or really project that ego. I think that's so important, as I said earlier, for me, when I go to speak, my belief is I'm going to to do what I can to help whatever event I'm at, it isn't about me at all. It's more about the audience. It's more about what can I inspire this audience with? What can I tell the audience and talk with the audience about, and how can I relate to them so that I'm saying something that they want to hear, and that's what I have to do. So if you had the opportunity to go back and talk to a younger Ivan, what would you tell him?   Ivan Cury ** 59:08 Cut velvet? No, there you go. No, what? I don't. I really don't. I don't know.   Michael Hingson ** 59:18 Talk Like a fish. More often   Ivan Cury ** 59:20 talk like a fish. More on there. Maybe. No, I really don't know. I don't know. I think about that sometimes, what it always seems to be a question, what? Really it's a question, What mistakes did you make in life that you wish you hadn't done? What door you wish Yeah, you would open that you didn't? Yeah, and I really don't, I don't know. I can't think of anything that I would do differently and maybe and that I think there's a weakness, because surely there must be things like that. I think a lot of things that happen to one in life anyway have to do with luck. That's not, sort of not original. But I was surprised to hear one day there was a. It. Obama was being interviewed by who was by one of the guys, I've forgotten his name that. And he was talking about his career, and he said he felt that part of his success had been a question of luck. And I very surprised to hear him say that. But even with, within with my career, I think a lot of it had to do with luck I happen to meet somebody that right time. I didn't meet somebody at the right time. I think, I think if I were to do so, if you would, you did ask the question, and I'd be out more, I would be pitching more. I think I've been lazy in that sense, if I wanted to do more that. And I've come to the West Coast quicker, but I was doing a lot of was in New York and having a good time   Michael Hingson ** 1:00:50 Well, and that's important too, yeah. So I don't know that I changed, I Yeah, and I don't know that I would find anything major to change. I think if somebody asked me that question, I'd say, tell my younger self that life is an adventure, enjoy it to the fullest and have fun.   Ivan Cury ** 1:01:12 Oh, well, that's yes. That was the I always believe that, yeah, yeah. It's not a question for me, and in fact, it's one of the things I told my kids that you Abraham Lincoln, you know, said that really in it, in a way a long time ago. He said that you choose you a lot of what you way you see your life has to do with the way the choices you make about how to see it, right? Yeah, which is so cool, right? And one of the ways you might see it says, have fun,   Michael Hingson ** 1:01:39 absolutely well, Ivan, this has been absolutely fun. We've been doing it for an hour, believe it or not, and I want to thank you for being here. And I also want to thank everyone who is listening for being with us today. I hope you've enjoyed this conversation, and I'd love to hear what your thoughts are. Please feel free to email me. I'd love to hear your thoughts about this. Email me at Michael h i at accessibe, A, C, C, E, S, S, i, b, e.com, so Ivan, if people want to reach out to you, how do they do that?   Ivan Cury ** 1:02:10 Oh, dear. Oh, wait a minute, here we go. Gotta stop this. I curyo@gmail.com I C, u, r, y, o@gmail.com There you go. Cury 1r and an O at the end of it, not a zero. I curyo@gmail.com Yeah.   Michael Hingson ** 1:02:30 Well, great. Well, thank you again, and all of you wherever you're listening, I hope that you'll give us a great review wherever you're listening. Please give us a five star review. We appreciate it, and Ivan, for you and for everyone else listening. If you know anyone else who ought to be a guest on our podcast, love to hear from you. Love an introduction to whoever you might have as a person who ought to come on the podcast, because I think everyone has stories to tell, and I want to give people the opportunity to do it. So once again, I want to thank you, Ivan, for being here. We really appreciate it. Thanks for coming on and being with us today. Thank you.   1:03:10 You have been listening to the Unstoppable Mindset podcast. Thanks for dropping by. I hope that you'll join us again next week, and in future weeks for upcoming episodes. To subscribe to our podcast and to learn about upcoming episodes, please visit www dot Michael hingson.com slash podcast. Michael Hingson is spelled m i c h a e l h i n g s o n. While you're on the site., please use the form there to recommend people who we ought to interview in upcoming editions of the show. And also, we ask you and urge you to invite your friends to join us in the future. If you know of any one or any organization needing a speaker for an event, please email me at speaker at Michael hingson.com. I appreciate it very much. To learn more about the concept of blinded by fear, please visit www dot Michael hingson.com forward slash blinded by fear and while you're there, feel free to pick up a copy of my free eBook entitled blinded by fear. The unstoppable mindset podcast is provided by access cast an initiative of accessiBe and is sponsored by accessiBe. Please visit www.accessibe.com . AccessiBe is spelled a c c e s s i b e. There you can learn all about how you can make your website inclusive for all persons with disabilities and how you can help make the internet fully inclusive by 2025. Thanks again for Listening. Please come back and visit us again next week.

Alice Kyteler's witchcraft trial shocked 14th century Ireland. Today, the charges against her are seen largely as nonsense, and more about personal vendettas and struggles for power. Research: Bailey, Michael D. “HISTORICAL DICTIONARY of WITCHCRAFT.” Scarecrow Press. 2003. Callan, Maeve Brigid. “The Templars, the Witch, and the Wild Irish: Vengeance and Heresy in Medieval Ireland.” Cornell University Press. 2015. “Dame Alice Kyteler.” Historic Kilkenny. https://www.historickilkenny.com/alice-kyteler Iribarren, Isabel. “Black Magic to Heresy: A Doctrinal Leap in the Pontificate of John XXII.” Church History , Mar., 2007, Vol. 76, No. 1 (Mar., 2007), pp. 32-60. Cambridge University Press on behalf of the American Society of Church History. https://www.jstor.org/stable/27644923 “Kilkenny Witch Trials.” Kilkenny Heritage Forum and Kilkenny Heritage Plan. https://kilkennyheritage.ie/2024/12/kilkenny-witch-trials/#:~:text=On%203rd%20November%201324%2C%20Petronilla,world%20for%20centuries%20to%20come. Pavlic, Brian A. “Lady Alice Kyteler Is Found Guilty of Witchcraft.” EBSCO. 2022. https://www.ebsco.com/research-starters/law/lady-alice-kyteler-found-guilty-witchcraft Ledrede, Richard. “A contemporary narrative of the proceedings against Dame Alice Kyteler, prosecuted for sorcery in 1324.” London. Printed for the Camden Society, by John Bowyer Nichols and Son. 1843. https://archive.org/details/b33096831/page/n11/mode/2up “A Medieval History.” Kyteler’s Inn. https://www.kytelersinn.com/history-of-the-inn/ Murphy, Mrs. C.J. “Alice Kyteler.” Old Kilkenny Review. 1953. https://kilkennyarchaeologicalsociety.ie/wp-content/uploads/2020/12/OKR1953-09-Claire-Murphy-Alice-Kyteler.pdf Neary, Anne. “The Origins and Character of the Kilkenny Witchcraft Case of 1324.” Proceedings of the Royal Irish Academy: Archaeology, Culture, History, Literature , 1983, Vol. 83C (1983), pp. 333-350. https://www.jstor.org/stable/25506106 Riddell, William Renwick. “First Execution for Witchcraft in Ireland.” Journal of Criminal Law and Criminology. Vol. 7, Issue 6. 1917. https://scholarlycommons.law.northwestern.edu/cgi/viewcontent.cgi?params=/context/jclc/article/1500/&path_info=83_7JAmInstCrimL_Criminology828_May1916toMarch1917_.pdf Seymour, John Drelincourt. “Dame Alice Kyteler the Sorceress of Kilkenny A.D. 1324 (Folklore History Series).” Read Books. 2011. Walsh, James. “The Popes and Science: THE HISTORY OF THE PAPAL RELATIONS TO SCIENCE DURING THE MIDDLE AGES AND DOWN TO OUR OWN TIME.” NEW YORKFORDHAM UNIVERSITY PRESS. 1915. Accessed online: https://www.gutenberg.org/files/34019/34019-h/34019-h.htm Williams, Bernadette. “The Sorcery Trial of Alice Kyteler.” History Ireland, vol. 2, no. 4, 1994, pp. 20–24. JSTOR, http://www.jstor.org/stable/27724208 See omnystudio.com/listener for privacy information.

This week on Health Matters, Courtney talks with Dr. Vivian Bea, Chief of Breast Surgical Oncology, and Dr. Evelyn Taiwo, a medical oncologist, at New York Presbyterian Brooklyn Methodist Hospital and Weill Cornell Medicine. For Breast Cancer Awareness Month, they discuss why breast cancer is on the rise among younger women, breast cancer risk factors, and the importance of screening. Dr. Bea and Dr. Taiwo also answer common questions about breast cancer, such as what age you can stop screening, and whether common items like deodorant or cell phones increase breast cancer risk.___Vivian Jolley Bea, MD, is Section Chief of Breast Surgical Oncology in the Department of Surgery at NewYork-Presbyterian Brooklyn Methodist Hospital. Dr. Bea received her masters degree in biology from Drexel University and her medical degree from Morehouse School of Medicine. Board certified in general surgery, Dr. Bea is an active member in numerous professional organizations, including the American College of Surgeons, American Society of Breast Surgeons, Society of Surgical Oncologists, and the Society of Black Academic Surgeons. Dr. Bea's areas of interest include breast cancer, benign breast disease, inflammatory breast disease, and high-risk management. She specializes in skin-sparing and nipple sparing mastectomies as well as oncoplastic breast conservation surgery. Dr. Bea is committed to community outreach, research, and eliminating breast cancer disparities.Dr. Evelyn Taiwo, MD, is a medical oncologist at NewYork-Presbyterian Brooklyn Methodist Hospital. She obtained her MD at Temple University School of Medicine in Philadelphia. Following her residency at Boston University Medical Center, she completed a three-year fellowship in hematology and oncology at the University of Texas Southwestern Medical Center in Dallas. Prior to joining Weill Cornell Medicine, Dr. Taiwo served as Assistant Professor of Medicine at the State University of New York, Downstate Medical Center in Brooklyn from July 2011-2019, and as Attending Physician and Site Director for the Hematology-Oncology Fellowship Program at Kings County Hospital. While at Kings County Hospital, she served in a leadership role as Director of the Breast Cancer Clinic, overseeing the operations, research activities, clinical care delivery, and education. As a researcher, Dr. Taiwo has contributed to a number of studies on cancer presentation in urban and minority patient populations.___Health Matters is your weekly dose of health and wellness information, from the leading experts. Join host Courtney Allison to get news you can use in your own life. New episodes drop each Wednesday.If you are looking for practical health tips and trustworthy information from world-class doctors and medical experts you will enjoy listening to Health Matters. Health Matters was created to share stories of science, care, and wellness that are happening every day at NewYork-Presbyterian, one of the nation's most comprehensive, integrated academic healthcare systems. In keeping with NewYork-Presbyterian's long legacy of medical breakthroughs and innovation, Health Matters features the latest news, insights, and health tips from our trusted experts; inspiring first-hand accounts from patients and caregivers; and updates on the latest research and innovations in patient care, all in collaboration with our renowned medical schools, Columbia and Weill Cornell Medicine.To learn more visit: https://healthmatters.nyp.org Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode of Uncommon Sense with Ginny Robinson, I further analyze the circumstances surrounding Charlie Kirk's assassination and the subsequent (and obvious) coverup. I also address listener questions, offering my current perspectives on Donald Trump and the many, many challenges of modern dating. -___---https://bakerbookhouse.com/pages/the-brand-sunday

In this episode of The Association Insights Podcast, we launch our Member Value Reimagined series with a bold and inspiring story from the American Society for Nondestructive Testing (ASNT). Host Meghan Henning sits down with Pat White, Director of Membership, and Nealy Wheat, Chief Financial & Administrative Officer, to explore how ASNT broke the mold—replacing a traditional dues-based model with a freemium structure that's already delivering surprising results.

Satire, Tropes, and Uncomfortable ConversationsMatthew and Riki examine the 2024 satirical film The American Society of Magical Negroes, starring Justice Smith. This provocative comedy tackles the "magical Negro" trope coined by Spike Lee—where Black characters exist primarily to help white protagonists—by imagining it as a real organization designed to keep white people comfortable. The film blends social commentary with romantic comedy as the protagonist must choose between his assigned role and his own desires.Questions We Discussed:What is the "magical Negro" trope and how has it appeared in films like The Green Mile, The Legend of Bagger Vance, and Ghost?Does the film work better as satirical sketch comedy than as a feature-length movie?Should we have avoided discussing this film as non-Black hosts, or is there value in these conversations across racial lines?Does the romantic comedy element undermine or enhance the film's social commentary?How does the character of Lizzie complicate the film's racial dynamics as a multiracial woman who "passes" as white?Is the final confrontation scene between Aaron and Jason genuine growth or does it center white comfort once again?Can characters like Guinan from Star Trek: The Next Generation or Morpheus from The Matrix fit this trope while still being well-developed?Why did this film generate such polarized reactions, particularly within Black media critique circles?**************************************************************************This episode is a production of Superhero Ethics, a The Ethical Panda Podcast and part of the TruStory FM Entertainment Podcast Network. Check our our website to find out more about this and our sister podcast Star Wars Generations.We want to hear from you! You can keep up with our latest news, and send us feedback, questions, or comments via social media or email.Email: Matthew@TheEthicalPanda.comFacebook: TheEthicalPandaInstagram: TheEthicalPandaPodcastsTwitter: EthicalPanda77Or you can join jump into the Star Wars Generations and Superhero Ethics channels on the TruStory FM Discord.Want to get access to even more content while supporting the podcast? Become a member! For $5 a month, or $55 a year you get access to bonus episodes and bonus content at the end of most episodes. Sign up on the podcast's main page. You can even give membership as a gift!You can also support our podcasts through our sponsors:Purchase a lightsaber from Level Up Sabers run by friend of the podcast Neighborhood Master AlanUse Audible for audiobooks. Sign up for a one year membership or gift one through this link.Purchase any media discussed this week through our sponsored links.

In this honest and vulnerable conversation, Adriane shares her extremely difficult journey as a wife who lost her husband to suicide in her late 20s. Adriane talks about her son, Braden, who was only 7 when his dad died by suicide. She also discusses how Braden struggled tremendously with his own suicidal ideation and how he lost his best friend to suicide at the age of 16.  Adriane laments the difficulty in finding a good therapy fit for her son, and how she struggled herself to deal with the grief and loss in unhealthy ways along. While she struggled with her own depression, Adriane talks about how she worked to find joy in her life again. In 2018, Braden graduated from high school, and Adriane learned about AFSP (https://afsp.org/). She had felt that she was alone in a boat in the ocean with no one to talk to, and AFSP gave her a place to talk about her experience. Since that time, Adriane has been very involved with AFSP. Adriane strives to be a healing balm for others, which is a critical part of her own healing journey. Adriane now finds joy in helping others in whatever capacity they need. Adriane concludes this episode by emphasizing the importance of talking about mental health, asking questions, and being supportive to someone who is struggling. Adriane encourages listeners to ask the direct question if there are concerns about suicide, and to utilize 988 as a resource for help.

When you're going through fertility treatments, you never imagine they will end without a baby. I didn't. I believed that if I tried hard enough, followed every step, and stayed committed, eventually I would have the child I dreamed of. But when IVF failed and motherhood didn't happen, I was completely unprepared and unsupported. That gap, the silence that follows when treatments end without children, is why I became a member of ASRM, the American Society for Reproductive Medicine, and serve in their Mental Health Providers group.  In October I am attending the ASRM annual congress with thousands of reproductive Endocrinologists, fertility doctors, IVF nurses, and fertility specialists from around the world. My mission is to make sure the voices of women who are childless after infertility are part of the conversation. For an upcoming podcast episode I will be interviewing a fertility doctor who not only treats patients but has gone through IVF herself. This is your opportunity to shape that conversation. ✨ What do you wish you had received when you left treatments without a baby? ✨ Were you offered support, and if yes what was most helpful? ✨ If you weren't, what do you think would have made the biggest difference? ✨ And what is one question you would love me to ask a fertility doctor about life after treatment?

Executive assistants and administrative professionals of all kinds are leaders with boundless potential and opportunities to improve their leadership skills. Take inspiration from executive leader Ellen Bailey to claim your seat at the table. Recorded at EA Ignite Spring 2025 and produced by the American Society of Administrative Professionals - ASAP. Learn more and submit a listener question at asaporg.com/podcast.

Dr. Heather Nixon is a Professor of Anesthesiology and the Division Chief of Obstetric Anesthesiology at the University of Illinois Hospital at Chicago where she has worked for the last 15 years. She completed her residency at the University of Illinois at Chicago Medical School and her Obstetric Anesthesiology Fellowship at Northwestern Memorial Hospital – Feinberg School of Medicine.  Her previous academic appointments include Residency Program Director, Associate Head for Education and Obstetric Anesthesiology Fellowship Director.    Dr. Nixon served on the Illinois Maternal Mortality Review Committee for 6 years.  She currently serves as the Anesthesiology Representative on the AWHONN (Association of Women's Health, Obstetric and Neonatal Nurses) Respectful Care Collaborative and a Contributor to the ELEVATE (Elevating Anesthesia Choices for Cesarean Delivery: A Roadmap to Patient-Centered Research and Quality Improvement) project. Nationally, she served as the Vice Chair for the American Society of Anesthesiologists Committee on Obstetric Anesthesia for six years and a member of the board of directors for the Society of Obstetric Anesthesia and Perinatology for the last 10 years.  Heather is the current Immediate President of the Society of Obstetric Anesthesia and Perinatology.  She is a recognized national and international speaker and is a passionate advocate for patient safety as it relates to medication management in anesthesiology and the patient experience in obstetric anesthesia care.  Notably, she is featured in the New York Time and Serial Productions “The Retrievals Season 2” for her quality improvement and safety work in the clinical area of intraoperative pain during cesarean delivery. Dr. Nixon has received numerous teaching awards from the Society of Obstetric Anesthesia and Perinatology, the American Society of Anesthesiologists, the Society of Education in Anesthesia and the American Medical Association.    CONNECT WITH DVORA ENTIN: Website: https://www.dvoraentin.com/ Instagram: https://www.instagram.com/dvoraentin YouTube: https://www.youtube.com/@misconceptionspodcast  

Sign Up for My Free Live Webinar! Download my Free Guide 'In My Perimenopause Era' Ever walked down the supplement aisle and felt totally overwhelmed? Collagen powders, protein shakes, gummies, hair growth vitamins—where do you even start, and what actually works? In this episode, I sit down with Dr. Glynis Ablon to talk through all the ways nutrition and supplements can support our skin, hair, and overall health. She shares her evidence-based approach to building a healthy foundation, the supplements she trusts, and even her personal routine (yes, she really has bottles by the sink, bed, and fridge!). We cover everything from collagen, vitamin D, creatine, and bone density support in menopause, to hair supplements like Nutrafol and Viviscal, gut health, stress management, and the Standard American Diet (SAD).  If you've ever wondered what supplements are worth your time, this episode is for you. Listen in, then share this conversation with a friend who's also navigating the supplement world. And don't forget to follow the show so you never miss an episode. Download the Free eBook 'Skincare Myths Busted' Key Takeaways: Why nutrition should always come first—and supplements should truly “supplement.” The best-studied supplements for skin, hair, nails, and healthy aging. Why collagen, vitamin D, and creatine are must-knows in midlife. Gut health, stress, and sleep as overlooked keys to glowing skin and strong hair. The truth about protein powders, sugar, raw dairy, and gummies. Which supplement brands Dr. Ablon actually trusts. Biohacking tools for longevity—what's hype vs. what's hopeful. Glynis Ablon, M.D., F.A.A.D., a native Californian, is a board-certified dermatologist with 27 years of experience, in medical, surgical, and aesthetic dermatology, completing her residency training at Baylor School of Medicine in Houston, Texas.  Dr. Ablon is an Associate Clinical Professor at UCLA and a national investigator and educator for pharmaceutical companies. She is also the first published author in the United States in mesotherapy.   She has published over 50 medical articles, two book chapters, and written three books. In addition, she is an on-camera medical consultant for The Doctors Show, ABC, CBS, NBC, KCAL, E! Entertainment, and Lifetime.   She is a Fellow of the American Academy of Dermatology, American Academy of Liposuction Surgery, American Society for Laser Medicine and Surgery, and American Society for Dermatologic Surgery to name a few. Dr. Ablon also received the IMCAS Research Award 2010 for innovative research on Botulinum Toxins. Follow Glynis Ablon here: https://www.instagram.com/drablon/?hl=en https://abloninstitute.com/   The Skin Real app is officially LIVE! Download it now. Want more expert skin advice without the overwhelm? Subscribe to The Skin Real Podcast wherever you listen, and visit www.theskinreal.com for dermatologist-backed tips to help you feel confident in your skin—at every age. Follow Dr. Mina here:-  https://instagram.com/drminaskin https://www.facebook.com/drminaskin https://www.youtube.com/@drminaskin https://www.linkedin.com/in/drminaskin/ Visit Dr. Mina at Baucom & Mina Derm Surgery Website: atlantadermsurgery.com Email: scheduling@atlantadermsurgery.com Call: (404) 844-0496 Instagram: @baucomminamd Thanks for tuning in. And remember—real skin care is real simple when you know who to trust. Disclaimer: This podcast is for entertainment, educational, and informational purposes only and does not constitute medical advice.

Can body positivity and weight loss medications like Ozempic and WeGovy coexist. Or are they destined to clash? This question has sparked debates across social media and medical offices everywhere. In this episode, I will explore the history of the body positivity movement from its 1960's roots with the National Association to Advance Fat Acceptance to its social media explosion in the 2010's. I will discuss how the movement challenged diet culture and promoted self-love regardless of size. Then, I will also talk about today's weight loss medication revolution and the tension it creates. Some feel that taking these drugs contradicts body positivity principles, while others face judgement for choosing medical intervention. I will address the stigma from both sides, the challenge of redefining health, and how to separate personal choice from cultural pressure. Tune in to discover why these two movements don't have to be at war and how you can find a middle ground of honoring your own health journey without judgment.   Episode Highlights: The history and evolution of body positivity movement How society judges people based on size and the ongoing work needed. The rise of drugs like Zepbound and WeGovy and their health benefits The tension between these two movements seeing it as incompatible to each other's principles. How to embrace both self-acceptance and medical tools for health.   Connect with Dr. Alicia Shelly: Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd   About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH.  Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014.  In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss,  where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, “Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''.   Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)

Discover how collaboration can strengthen our field! Join special guest Dr. Debby Basu as she shares the latest American Society for Clinical Pathology (ASCP) projects and initiatives designed to support and empower the clinical laboratory workforce — including opportunities that could directly benefit you.

Leah Warwick is the senior content manager for the American Society of Administrative Professionals (ASAP). Maggie Olson is the Founder of Nova Chief of Staff, the premier destination for Chief of Staff education and development.In this episode of The Leader Assistant Podcast, I talk with Leah and Maggie about the state of the administrative profession, skill gaps, professional development, and more.Show Notes -> leaderassistant.com/343--In-person meeting planning can be a lot to manage. That's where TROOP Planner comes in. TROOP Planner is built to make life easier for busy assistants like yourself. Whether you're organizing an executive offsite, department meeting, or team retreat, TROOP keeps it simple, fast, and organized.Visit leaderassistant.com/troop to learn more! --Are you ready to level up? Enroll in The Leader Assistant Academy at leaderassistant.com/academy to embrace the Leader Assistant frameworks used by thousands of assistants. --Automate scheduling with YouCanBookMe by Capacity. Sign up for a FREE trial -> leaderassistant.com/calendar.More from The Leader Assistant... Book, Audiobook, and Workbook -> leaderassistantbook.com The Leader Assistant Academy -> leaderassistantbook.com/academy Premium Membership -> leaderassistant.com/membership Events -> leaderassistantlive.com Free Community -> leaderassistant.com/community

Discover expert insights on kidney stone prevention and management in this podcast episode featuring a physician, dietitian, pharmacist, and patient. Learn about key kidney stone risk factors and explore how dietary adjustments can reduce stone recurrence. Experts discuss fluid intake strategies, medication considerations, surgical indications, and even unconventional questions about roller coasters' impact on stone passage. Tune in for actionable advice, myth-busting discussions, and interprofessional perspectives.   On today's episode we heard from: Melanie Betz, MS, RD, CSR, FNKF, FAND is a nationally recognized renal dietitian and the Founder & CEO of The Kidney Dietitian. She is a Certified Specialist in Renal Nutrition and a Fellow of both the National Kidney Foundation and the Academy of Nutrition & Dietetics. Melanie has published extensively on kidney stone prevention and nutrition, and has presented at numerous state, national, and international conferences on the topic. Through her clinical work, research, and educational outreach, she is dedicated to helping patients and professionals understand the critical role of diet in kidney health. Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS is a Clinical Associate Professor at West Virginia University School of Pharmacy and a Clinical Pain & Addiction Pharmacist. With expertise in pain management, substance use disorders, and geriatric care, he brings both clinical and personal perspectives to kidney stone discussions. Mark has shared his experience through the Pain Pod podcast, PAINWeek presentations, and a published article detailing his own kidney stone journey. Mary Raines, CRA is a retired clinical research associate with more than 30 years of experience in medical research. After learning she needed a kidney transplant, she dedicated herself to advocacy and now serves as a Patient Advocate with the National Kidney Foundation and other kidney health organizations. Mary brings both professional expertise and personal experience to her work, amplifying the voices and needs of people living with kidney disease. Andrew Rule, MD, MSc is a Professor of Medicine and Consultant Nephrologist at the Mayo Clinic in Rochester, Minnesota. He divides his time between clinical care, research, and education, with a particular focus on kidney stone disease and its link to chronic kidney disease. Dr. Rule has published extensively on the epidemiology of kidney stones and provides specialized care in the Mayo Clinic's nephrology stone clinic. Bryan Tucker, DO, MS, FASN is an Assistant Professor of Medicine in Nephrology at Baylor College of Medicine, where he serves as a clinician educator teaching medical students, residents, and fellows while caring for patients in both inpatient and outpatient settings. He holds a master's degree in nutrition from Columbia University and completed his nephrology fellowship at Yale. A Fellow of the American Society of Nephrology, Dr. Tucker has authored numerous peer-reviewed publications and book chapters and is an active contributor to The Kidney Commute podcast.   Additional Resources: Kidney Stone Information Earn CME Credit Here Do you have comments, questions, or suggestions? Email us at NKFpodcast@kidney.org. Also, make sure to rate and review us wherever you listen to podcasts.  

Matters Microbial #109: Bat-Crazy About Rabies September 26, 2025 In honor of World Rabies Day, Dr. Rodney Rohde, Regents Professor at Texas State University,  joins the #QualityQuorum to discuss rabies and some of the strategies used to limit the influence of that devastating viral disease. Host: Mark O. Martin Guest: Rodney Rohde Subscribe: Apple Podcasts, Spotify Become a patron of Matters Microbial! Links for this episode An overview of rabies from the CDC. A historical overview of rabies and Louis Pasteur. The global impact of rabies. Bats and rabies. A podcast exploring rabies and myths about vampires and werewolves. A wonderful video about rabies SO worth your time. A video with three physicians about rabies. A detailed review of rabies and the rabies virus. The lifecycle of the rabies virus. Various tests for rabies. The vaccines for rabies. Rabies research at the CDC. Use of an oral rabies vaccine to eliminate epizootic rabies in coyotes and gray foxes in Texas. Information about World Rabies Day. The Contagion Live website, including podcasts by Dr. Rohde. A video from Dr. Rohde about medical laboratory science. A video from Dr. Rohde about rabies. Dr. Rohde's biography from the American Society for Microbiology. Dr. Rohde's faculty website. Dr. Rohde's personal website. Intro music is by Reber Clark Send your questions and comments to mattersmicrobial@gmail.com

Presented by the Cytopathology Program Directors Committee   Diva Salomao, MD, Chair & Frida Rosenblum, MD, Vice Chair   Dr. Kim Ely interviews Dr. Sara Monaco, the upcoming President-Elect and current Vice President of the American Society of Cytopathology, regarding her experience with implementing tele-cytology for rapid on-site evaluation. Together, they demystify the technology by introducing the listener to the necessary equipment and explaining the different platforms. Learn ways to incorporate the trainee into these remote evaluations and novel ways to assess their competency.   Sara E. Monaco, MD ASC Vice President Geisinger Medical Center Danville, Pennsylvania   Kim A. Ely, MD Member, ASC Cytopathology Program Directors Committee Vanderbilt University Medical Center Nashville, Tennessee

Don't let others define your EA or admin brand for you. Take notes from expert Jodie Mears to rewrite your story. Recorded at EA Ignite Spring 2025 and produced by the American Society of Administrative Professionals - ASAP. Learn more and submit a listener question at asaporg.com/podcast.

What's up theology nerds! On this episode, I had the absolute privilege of sitting down with Dr. Grant Wacker, one of America's preeminent historians of religion, and man did he deliver. We dove deep into his fascinating "Bushman test" - the idea that when writing history, you should do so with the understanding that you might someday encounter your subjects in heaven. That framework of being both critical and sympathetic really animated our whole conversation. But here's the kicker - I asked Grant to reflect on the defining moments in American religion as we approach our 250th anniversary, and he came back with 11 (not 10!) pivotal moments that have shaped who we are religiously as a nation. From the expansionist impulse of colonization to the power of renewal movements, from the subjection of Native Americans to the role of reform theology, Grant unpacked these threads with the wisdom that only comes from decades of wrestling with this stuff. We also got into his work on Billy Graham, the birth of Pentecostalism, and how technology has revolutionized religious movements. This is the kind of conversation that helps you understand not just where American religion came from, but where it might be headed. Grab your coffee and settle in - this one's worth savoring. You can WATCH the conversation on YouTube Dr. Grant Wacker is the Gilbert T. Rowe Professor Emeritus of Christian History at Duke Divinity School and the author of Heaven Below: Early Pentecostals and American Culture, America's Pastor: Billy Graham and the Shaping of a Nation, and One Soul at a Time: The Story of Billy Graham. He is a former president of the American Society of Church History and has served as a senior editor of the quarterly journal Church History: Studies in Christianity and Culture. ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Theology Beer Camp ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠is a unique three-day conference that brings together of theology nerds and craft beer for a blend of intellectual engagement, community building, and fun. Guests this year include John Dominic Crossan, Kelly Brown Douglas, Philip Clayton, Stacey Floyd-Thomas, Jeffery Pugh, Juan Floyd-Thomas, Andy Root, Grace Ji-Sun Kim, Noreen Herzfeld, Reggie Williams, Casper ter Kuile, and more! ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Get info and tickets here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. _____________________ This podcast is a ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Homebrewed Christianity⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ production. Follow ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠the Homebrewed Christianity⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Theology Nerd Throwdown⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, & ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The Rise of Bonhoeffer⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ podcasts for more theological goodness for your earbuds. Join over 75,000 other people by joining our⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Substack - Process This!⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Get instant access to over 50 classes at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.TheologyClass.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Follow the podcast, drop a review⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, send ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠feedback/questions⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ or become a ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠member of the HBC Community⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Learn more about your ad choices. Visit megaphone.fm/adchoices

Our guest today, Dr. Chris Walinski, is a dentist, researcher, MasterChef contestant, and prostate cancer survivor. His story is an inspiring one of persistence, adaptation, reinvention and turning adversity into advocacy. Chris shares how his childhood independence led to a lifelong passion for cooking, how his wife nudged him into the MasterChef spotlight, and how a life-altering cancer diagnosis reshaped his perspective on food, prevention, and living fully. You'll learn: - What Chris learned from competing on MasterChef (and from Gordon Ramsay...) - How his cancer journey shifted his mindset on prevention, nutrition, and resilience - The role of antioxidants, anti-inflammatory foods, and gut health in longevity - The top prostate-friendly foods - The importance of cutting back on ultra-processed foods, red meat, alcohol, and sugar - Chris's lessons on reinvention in midlife and retirement ________________________ Bio Dr. Chris Walinski has been an author, inventor and trusted expert in dentistry for over 25 years and has authored a dental text that has been translated into 10 languages. He is one of the earliest dentists to use lasers in dentistry, Dr. Walinski has been called upon to make presentations around the world at professional conferences and universities. Since 2004, he has taught thousands of doctors on the topics of cosmetics, minimally-invasive dentistry, technology and the use of lasers. His lectures have taken him to almost 50 countries at this point. Dr. Walinski is the Executive Director of the World Clinical Laser Institute and the International Dental Laser Research Institute, and is a Founding member of the American Academy of Oral Systemic Health. He is a Diplomate and Past-President of the World Congress of Minimally Invasive Dentistry. He is a proud member of Sigma Xi, the Scientific Research Honor Society, and his Fellowships include the International College of Dentists, The Royal Society of Medicine, The International Association for Laser Dentistry and the American Society for Lasers in Medicine and Surgery. Dr. Walinski's lifelong love of cooking resulted in him competing on this season's MasterChef on FOX. He also has three lovely children and is married to the love of his life and wife of six years. They live together with their English Springer Spaniel, Lacey. _________________________ For More on Chris Walinski The Prostate Site 3 recipes to try: ‘MasterChef' alum's cake, soup, rice - Ohio State Alumni Magazine _________________________ Prostate Cancer Testing Free Prostate Cancer Testing Near You NFL Crucial Catch - FIND A CANCER SCREENING LOCATION NEAR YOU* _________________________ Podcast Conversations You May Like How Not to Age – Dr. Michael Greger The Well-Lived Life – Dr. Gladys McGarey Take Charge of Your Well-Being – John La Puma, MD _________________________ About The Retirement Wisdom Podcast There are many podcasts on retirement, often hosted by financial advisors with their own financial motives, that cover the money side of the street. This podcast is different. You'll get smarter about the investment decisions you'll make about the most important asset you'll have in retirement: your time. About Retirement Wisdom I help people who are retiring, but aren't quite done yet, discover what's next and build their custom version of their next life. A meaningful retirement doesn't just happen by accident. Schedule a call today to discuss how the Designing Your Life process created by Bill Burnett & Dave Evans can help you make your life in retirement a great one — on your own terms. About Your Podcast Host Joe Casey is an executive coach who helps people design their next life after their primary career and create their version of The Multipurpose Retirement.™ He created his own next chapter after a 26-year career at Merrill Lynch, where he was Senior Vice President and Head of HR for Global Markets & Investment ...

A new study shows weight loss drugs like Wegovy and Zepbound don't just help with losing weight they may also protect the heart and save lives. In this episode, we look at a new study that followed over 90,000 people with obesity, type 2 diabetes, and heart failure. The results show that drugs like Wegovy and Zepbound don't just help with weight loss, they can cut the risk of death or hospitalization for heart failure nearly in half. We'll talk about why that matters, how these medications actually work in the body, and what you should know about side effects and access. Most importantly, we'll explore why this research could change how we think about treating obesity not just as a matter of weight, but as a way to save lives. Tune in to the full episode to hear how these weight loss drugs could also protect your heart.   Episode Highlights: The new JAMA study on Wegovy and Zepbound and their impact on heart health. How GLP-1 medications work in the body to lower risk. Why this matters for people with obesity, diabetes, and heart disease. Side effects, diet, and exercise considerations when using these drugs. Challenges with access and cost of these medications.   Connect with Dr. Alicia Shelly: Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd   About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH.  Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014.  In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss,  where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, “Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''.   Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)

Listen to today's podcast... When you think of stress and food, you are often told to stay away from treats, like ice cream cones. Ice cream: My favourite food. Creamy. Cold. Sweet. Hard or Soft…doesn't matter. I love ice cream. It can be high in fat and it contains a lot of sugar. And it's not the kind of snack food that I should have everyday…though wouldn't that be absolutely wonderful? An ice cream cone has some definite pros. Ice cream may help in maintaining weight. How interesting is that?  Ice cream for weight control.  Research from the American Society of Experimental Biology found that a diet that included dairy prevented about 50 percent of weight regain and 80 percent of fat regain after the animals had lost weight and were allowed to eat at will.  Now this research was done with animals, but if it works there it may work on humans….I would at least like to be a part of the experimental group…test group…not the control group. Ice cream may help me to keep my girlish figure. The North American Association for the Study of Obesity found in a study of 800 men and women that those who ate the most calcium were also the leanest. Research from Baylor College of Medicine and Texas Woman's University in Houston reported an association between the consumption of low-fat milk and dairy products and a lower waist-to-hip ratio. Ice cream may keep me from shrinking. Calcium is essential in preventing osteoporosis.  One reasonable (insert small) serving of ice cream can give you 10% of your daily calcium intake.  Did you know that: Ice cream is not a new treat…people have been creating frozen delicacies since 400 BC Britain's Margaret Thatcher was part of a research team that helped to develop soft ice cream The average American eats 18.3 litres of ice cream each year while Canadians eat 8.7 litres.  Japan has the lowest consumption with .01 litres per year. Take One Action Today To Build Your #Resiliency!      Here are my tips For Building Resilience By Celebrating National Ice Cream Cone Day: Ice cream can be a healthy treat.  But it is a treat.  I have nothing else…just go out and celebrate. Now which kind to choose…DQ, Kawartha Dairy, soft, hard, dipped, sauced, fruit, chocolate….. #mentalhealth #hr

To date, Michael P. Link has the unique honor of being the only pediatric oncologist to have served as president of the American Society of Clinical Oncology. Link, who is the Lydia J. Lee Professor in Pediatric Oncology at Stanford University, appeared on the Cancer History Project Podcast in conversation with Paul Goldberg, co-editor of the Cancer History Project and editor and publisher of The Cancer Letter.In honor of Childhood Cancer Awareness Month, Link revisits what drew him to pediatric oncology, his auspicious mentors, his 2011-2012 ASCO Presidential term—and his concerns about what he's seeing in oncology today.Over the course of his career, Link has seen a childhood cancer cure rate increase from a mere 40% to closer to 90%. But he's concerned about how the field of oncology is being impacted today.In his 2012 Presidential address, Link said:“There is another lesson from our children—that an ounce of prevention is worth a pound of cure. This is a lesson not just from pediatric oncology, but from pediatrics in general. Prevention strategy through immunization has proven to be one of the greatest triumphs of pediatrics and of modern medicine. Rather than diagnosing and treating diphtheria, widespread immunization simply eliminated it as a health problem in North America. The near eradication of measles, polio, and serious infections from H Influenzae is a similar triumph.”He expressed shock about how things have changed in 2025. “I'm a pediatrician, so here I am and they have measles? I mean really, measles in 2025? How is that possible?” Link said. “I never thought I'd be in a position where I have to talk to people about measles and polio and chickenpox as a threat... And measles, it's a matter of how serious your illness is going to be, and if you're immunocompromised it's life threatening.”Other concerns from his time as ASCO President have reemerged—or never really gone away.In 2012, Link said, “But all this newfound insight into these diseases and their treatment is only as good as our ability to deliver what we know. The current chemotherapy shortage is emblematic of the precarious nature of the path between the discovery and the delivery of our most exciting new findings.”Speaking on the podcast, Link called this an issue of “whack-a-mole”—where new drugs go into shortage on a regular basis. “Can you believe that here we are in whatever year it is, 20-whenever the next shortage is going to come and we don't have access to this?”A transcript of this conversation, along with an archive of related content, is available on the Cancer History Project: https://cancerhistoryproject.com/article/michael-link-podcast/ 

Dean's Chat host, Drs. Jeffrey Jensen and Johanna Richey, welcome APMA leadership, President Dr. Brooke Bisbee, and CEO Meghan McClelland, to the podcast! This weekend they are at the ASPE (American Society of Podiatric Executives Professionals) meeting in Boston! This discussion covers a lot of topics, addressing issues in our profession that are definately on the "front burner". Salary Survey! ACGME! Student Recruitment! Processes to achieve optimal results! Unification of the profession! Branding the profession - who are we? Tune in for this insightful, timely discussion of current important issues in our great profession! Notes on the ASPE meeting this weekend in Boston. The American Society of Podiatric Executives (ASPE) is a professional association made up of the executive directors and senior staff of state and regional podiatric medical associations across the United States. It serves as the “association of associations” for podiatry—essentially the network of the people who run the state and regional DPM organizations. Key Roles and Purposeupport & Collaboration: ASPE provides a forum for state society executives to share best practices, exchange ideas, and coordinate on issues affecting podiatric medicine nationwide. •Education & Training: It organizes meetings, workshops, and resources to help these executives strengthen their own associations—everything from member services to legislative advocacy. •Policy & Advocacy Alignment: ASPE often works in concert with the American Podiatric Medical Association (APMA) to ensure consistency in policy, legislative priorities, and messaging across states.

“The Nitrogen Value of Cover Crops” with Dr. Guillermo Marcillo. Cover crops are known for their ability to provide economic and ecosystem services to farmers, including, for example, impacting soil nitrogen. But how much nitrogen, exactly, can cover crops add or remove and how do we find out? In this episode, Guillermo joins me to discuss his work collating research data to get to the bottom of cover crop nitrogen replacement values. Tune in to learn: ·         What a nitrogen replacement value is ·         Why negative nitrogen replacement values are sometimes a positive ·         Which cover crops have, generally, which nitrogen replacement values ·         How nitrogen replacement values can be reverse engineered from existing data If you would like more information about this topic, this episode's paper is available here: https://doi.org/10.1002/ael2.70006 This paper is always freely available. Contact us at podcast@sciencesocieties.org or on Twitter @FieldLabEarth if you have comments, questions, or suggestions for show topics, and if you want more content like this don't forget to subscribe. If you'd like to see old episodes or sign up for our newsletter, you can do so here: https://fieldlabearth.libsyn.com/. If you would like to reach out to Guillermo, you can find him here: gmarcillo@wtamu.edu Resources CEU Quiz: https://www.rev.com/app/transcript/NjhjYWFkNTBhZDQ3ZGFjZGUyZjMxYmQ4ajBOeXVVX3ZKb2t5/o/VEMxMDIwODkyMDA5 Transcripts: https://www.rev.com/app/transcript/NjhjYWFkNTBhZDQ3ZGFjZGUyZjMxYmQ4ajBOeXVVX3ZKb2t5/o/VEMxMDIwODkyMDA5 Water working group at West Texas A&M University: https://www.wtamu.edu/academics/college-engineering/water-working-group/people.html Practical Farmers of Iowa: https://practicalfarmers.org/ Precision Sustainable Agriculture: https://www.precisionsustainableag.org/ Field, Lab, Earth is Copyrighted by the American Society of Agronomy, Crop Science Society of America, and Soil Science Society of America.

American Society v. UPCODES

Dr. Tanya Thomas and Dr. Aparna Jotwani join the podcast to discuss the new Oncology Nursing Society and American Society of Clinical Oncology evidence-based guideline on the management of antineoplastic extravasation. They discuss recommendations from the expert panel on: management of extravasation of vesicant or irritant with vesicant properties antineoplastic agents, management of extravasation of paclitaxel or docetaxel, use & duration of thermal compress, and escalation of care. They share the importance of this comprehensive interdisciplinary guideline, highlight the algorithm as a useful tool for clinicians, and outline the outstanding questions related to the management of extravasation. Read the full guideline, “ONS/ASCO Guideline on the Management of Antineoplastic Extravasation” at www.asco.org/supportive-care-guidelines TRANSCRIPT This guideline, clinical tools, and resources are available at www.asco.org/supportive-care-guidelines. Read the full text of the guideline and review authors' disclosures of potential conflicts of interest in the JCO Oncology Practice, https://ascopubs.org/doi/10.1200/OP-25-00579  Brittany Harvey: Hello and welcome to the ASCO Guidelines podcast, one of ASCO's podcasts delivering timely information to keep you up to date on the latest changes, challenges, and advances in oncology. You can find all the shows, including this one, at asco.org/podcasts. My name is Brittany Harvey, and today I'm interviewing Dr. Tanya Thomas, clinical chair of the guideline and clinical nurse specialist from University of Virginia Health, and Dr. Aparna Jotwani, medical oncologist from Baylor College of Medicine, authors on "Management of Antineoplastic Extravasation: Oncology Nursing Society – American Society of Clinical Oncology Guideline." Thank you for being here today, Dr. Thomas and Dr. Jotwani. Dr. Aparna Jotwani: Thank you. Dr. Tanya Thomas: Thank you for having us. Brittany Harvey: And then before we discuss this guideline, I'd like to note that ASCO takes great care in the development of its guidelines and ensuring that the ASCO conflict of interest policy is followed for each guideline. The disclosures of potential conflicts of interest for the guideline panel, including Dr. Thomas and Dr. Jotwani, who have joined us here today, are available online with the publication of the guideline in JCO Oncology Practice, which is linked in the show notes. So then to dive into the content here, Dr. Thomas, could you start us off by providing an overview of both the scope and the objectives of this guideline? Dr. Tanya Thomas: Yes, so the objective of this guideline is to provide the evidence-based recommendations to help support our interdisciplinary teams, including the oncologist, the advanced practice providers, pharmacists, and nurses who are involved in the care and management of patients who are experiencing an extravasation of an antineoplastic agent. While rare, the antineoplastic and certain chemotherapy extravasations are oncologic emergencies. The recommendations are to minimize negative consequences and provide a standardized approach to the care when such an event occurs. Dr. Aparna Jotwani: I would add that our scope is limited to intravenous antineoplastic vesicants, irritants, and irritants with vesicant potential. The scope of the guideline applies to the care team for adult oncology patients receiving treatments through venous access. Outside the scope is management of extravasation during other routes of treatment administration, such as intraperitoneal, intravesical, and hepatic arterial infusion. Our recommendations regarding vascular access for therapy or interventions to prevent extravasations are also outside of the scope for this guideline. Brittany Harvey: Understood. I appreciate that background and understanding what's in scope and what's out of scope for this guideline. So then I'd like to pivot and talk about the key recommendations of this guideline across the clinical questions. So first, Dr. Jotwani, what does the panel recommend for patients with extravasation of vesicant or irritant with vesicant properties antineoplastic agents? Dr. Aparna Jotwani: The panel strongly recommends for all classes where an antidote exists to proceed with using the antidote. Recommendations for paclitaxel and docetaxel are specifically addressed in a recommendation. This is further detailed in Tables 1 and 4 within the guideline. Evidence on the use of antidotes for extravasation is limited to nonrandomized, uncontrolled, observational studies and case series. Placebo-controlled trials on this topic would be unethical. There is also a lack of comparative data for different antidote strategies. However, potential benefits of using the antidotes include tissue preservation and avoiding tissue necrosis. In developing the guidelines, we had an in-person roundtable discussion and weighed risks and benefits to ensure patient safety above all else. Brittany Harvey: I appreciate that description of the recommendation here. So then you just mentioned that there's a specific recommendation for paclitaxel and docetaxel. So what is recommended for those patients with extravasation of paclitaxel or docetaxel? Dr. Aparna Jotwani: So here, we conditionally recommended the specific use of hyaluronidase as the antidote. This was based on five studies that all used hyaluronidase as an antidote to lower the risk of tissue necrosis. In the studies included, with a subgroup of patients that experienced taxane-related extravasation, development of necrosis ranged from 0% to 0.83% among the patients who received an antidote. The potential harms associated with this were likely trivial. Brittany Harvey: Thank you for providing that recommendation as well. So then the next section of the guideline, Dr. Thomas, what does the expert panel recommend for use and duration of thermal compress? Dr. Tanya Thomas: So the expert panel actually recommends the use of thermal compresses, and the recommendations are based on the available literature for the various agents and the actual time frames most frequently used for the compress application. The utilization of a thermal compress is recommended for 15 to 20 minutes at a time for 3 to 4 times daily, at least for the first 48 to 72 hours after that extravasation occurs. The actual frequency and duration may vary based on the extent of the extravasation and the agent involved in that extravasation. The intent of the warm compress is to help disperse the agent and reduce the localized accumulation of the agent, whereas the cold compress, it actually helps prevent the dispersion or the spread of the agent while allowing the antidote to help neutralize that agent. Warm compresses are recommended for extravasations involving the vinca alkaloids, etoposide, oxaliplatin, and the taxanes - paclitaxel and docetaxel - only when coadministering the antidote hyaluronidase. The use of a cold compress is actually recommended for extravasations involving the anthracyclines, antimetabolites, alkylating agents, and taxanes when coadministration of the antidote hyaluronidase does not occur. Brittany Harvey: Understood. Those specific and actionable recommendations are really key for clinical practice. So then, following those recommendations, how does the guideline address escalation of care and surgical referral for patients with central line extravasation? Dr. Tanya Thomas: So this topic actually had a lot of discussion. And while there is not enough evidence to make strong recommendations, the expert panel recognized that surgical referrals should be considered in certain scenarios. Dr. Aparna Jotwani: We discussed that certain scenarios would include high-risk populations, such as patients that are receiving DNA-binding vesicants, those with high-volume estimated extravasation, and those with CTCAE grade 2, which would be erythema associated with symptoms such as edema, pain, induration, and phlebitis, or grade 3, which would be symptoms of ulceration or necrosis or concern for severe tissue damage, or grade 4, where you would have a life-threatening consequence extravasation, may have a greater likelihood of benefiting from surgical referral and/or escalation of care as deemed appropriate. Brittany Harvey: Great. And yes, it's really important to provide all of these recommendations that you've both just gone through, even when we're faced with very low evidence. So then, Dr. Thomas, in your view, what is the importance of this guideline, and how will it impact clinical practice? Dr. Tanya Thomas: So when extravasations occur in the clinical setting, members of the interdisciplinary team can be faced with barriers related to where to look for the information, how to find all the relevant information in one concise place, how to provide education to the patient about how to care for the site of extravasation in the home setting, and also when to escalate to specialized teams. This can actually cause some added stress and anxiety, and in certain circumstances, may lead to delays in efficient management. This guideline provides the resource clinicians have been looking for. It includes comprehensive recommendations for antineoplastic extravasations in one guideline while also providing a one-page algorithm with the key information regarding the management of the extravasations. This allows all levels of providers to have evidence-based recommendations regarding initial management of the extravasation, for instance, how to manage the infusion, key site assessment reminders, available antidotes, and the use of thermal compress; the required documentation, recommended follow-up scheduling, in addition to key aspects of the patient education. This type of guidance is not found in any other single document regarding antineoplastic extravasation. Having this document readily available at the point of care potentially can reduce time required for providers to search for management recommendations and also provide consistency in patient education and follow-up management scheduling. It reduces uncertainty within interdisciplinary teams and can help inform policy development for clinicians to approach extravasations with confidence. Brittany Harvey: Absolutely. I agree that this is an incredible resource for clinicians with the recommendations, the algorithm that you mentioned, and the supporting evidence that underpins these recommendations to really provide both efficient and effective care for patients. So beyond the impact for clinical practice, Dr. Jotwani, how will these guideline recommendations affect patients receiving antineoplastic treatment for cancer? Dr. Aparna Jotwani: Exactly. In addition to the clinical care team, we want to help and benefit our patients. So, oncology patients that experience extravasations are at risk for, aside of the side effects of tissue necrosis and infection, they also are at risk for delay of cancer treatment. In making these guidelines, we kept in mind the cost and the efforts for patients, additional visits that they could incur, additional time and supplies for care of the extravasation, as well as cost. Our guideline aims to provide an evidence-based approach to the care of oncology patients receiving antineoplastic intravenous therapy. While there are gaps in the data due to the nature of these events, based on careful literature review, these guidelines serve as a basis for quality, standardized oncology care during extravasation. Personally, I hope our graphics especially can be used across the systems to guide clinical care. Brittany Harvey: Definitely. We hope that these recommendations improve treatment and treatment outcomes for all patients receiving antineoplastic treatment for cancer. So then you've also just mentioned some gaps in the literature. So Dr. Thomas, I'd like to turn to you to wrap us up and ask, what are the outstanding questions for the management of antineoplastic extravasation? Dr. Tanya Thomas: Yes, that's a good question. Two of the main outstanding questions are related to the management of extravasations involving the novel agents and extravasations involving multi-agent regimens. The current literature regarding how to effectively manage the multi-agent regimens, for instance, there is no clear guidance for managing the extravasation for someone who is receiving a regimen that involves simultaneous administration of, let's say, a vinca alkaloid and an anthracycline. One of those agents requires a warm compress while the other requires a cold compress, and there are different antidotes for those two agents. Additionally, there has not been a lot of published information on the impact of extravasation of those novel agents like the antibody-drug conjugates. With the pace of the drug development, a subgroup of the guideline panelists actually are exploring case reports specific to novel agents to help inform some future work. Brittany Harvey: Yes, we'll look forward to learning more about how to address these ongoing issues and potentially impact guideline recommendations in the future as well. So I want to thank you both so much for your work to develop this incredibly important guideline, and thank you for your time today, Dr. Thomas and Dr. Jotwani. Dr. Aparna Jotwani: Thank you for the opportunity. Dr. Tanya Thomas: Yes, thank you. Brittany Harvey: And finally, thank you to all of our listeners for tuning in to the ASCO Guidelines podcast. To read the full guideline, go to www.asco.org/supportive-care-guidelines. I also encourage you to check out the companion episode on this guideline on the ONS podcast, available on Amazon Music, Apple Podcasts, Spotify, and YouTube Music. And finally, you can also find many of our guidelines and interactive resources in the free ASCO Guidelines app, which is available in the Apple App Store or the Google Play Store. If you've enjoyed what you've heard today, please rate and review the podcast and be sure to subscribe so you never miss an episode. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.  

By uncovering critical sex-based differences related to brain and metabolic health, researchers Gillian Einstein and Minna Woo are making the case that tailored interventions are key to improving health outcomes for women — and everyone else. Through their work exploring how conditions from Alzheimer's to kidney disease can have varied effects depending on a patient's sex, they underscore what the medical community as a whole can learn from experts in women's health: Things aren't as simple as we want to believe. In this bonus episode, recorded live on May 8, 2025, at the MaRS Impact Health Conference, Einstein and Woo discuss the complexity of biology, the challenges of funding and why they're optimistic that things are changing.Featured in this episode:Gillian Einstein is the Wilfred and Joyce Posluns Chair in Women's Brain Health and Aging and a psychology professor of psychology at the University of Toronto. She's also an adjunct scientist at Baycrest and Women's College Hospitals, and an honorary doctor of medicine at Linköping University, Sweden. Her lab's current focus is on estradiol loss as well as how stigma and immigration affect memory and cognition in diverse populations of women.Minna Woo is currently the director of the Banting and Best Diabetes Centre at the University of Toronto and recently completed a 10-year term as division director of endocrinology and metabolism at the Toronto General Hospital, University Health Network (UHN). She now holds the Ajmera Chair in Molecular Diabetes Research at the Toronto General Hospital Research Institute and is a clinician scientist and a staff endocrinologist providing diabetes and endocrine care at UHN. Her laboratory focuses on molecular mechanisms that determine the pathogenesis of insulin resistance and related diseases. She has published more than 100 research articles and her research is internationally recognized as a member elect of the American Society of Clinical Investigation.Katherine Ward is an award-winning journalist currently working with Global News in Toronto. She joined the team in 2018 and has covered a wide range of stories taking her all over Ontario. This year, Ward was also part of an investigative team that exposed the prevalence of lead contamination in drinking water. “Tainted Water” went on to win a national award with Canada's Radio Television Digital News Association.Further reading: • From body to brain: Understanding how sex and gender contribute to brain health as we age• More women get Alzheimer's than men. It may not just be because they live longer• Sleep quality and the menstrual cycle• Breaking down sex and gender barriers in search of precision medicine• Canada accelerates diabetes researchSubscribe to Solve for X: Innovations to Change the World here.  Solve for X is brought to you by MaRS, North America's largest urban innovation hub and a registered charity. MaRS supports startups and accelerates the adoption of high-impact solutions to some of the world's biggest challenges. For more information, visit marsdd.com.

Gian Pazzia is the Chairman & Chief Strategy Officer at KBKG, where he oversees all strategic initiatives for one of the nation's leading specialty tax firms. With over 25 years of experience in the cost segregation industry, Gian is a recognized authority in his field and a former President of the American Society of Cost Segregation Professionals (ASCSP). During his tenure, he spearheaded the publication of the first technical standards for cost segregation reports and worked closely with the IRS on audit techniques, repair regulations, and landmark tax cases. As one of the first professionals in the U.S. to earn the Certified Cost Segregation Professional (CCSP) designation, Gian has provided expert testimony before the IRS and has been published in journals such as Accounting Today, AICPA's Tax Advisor, and Bloomberg Tax. Before joining KBKG, he worked at two of the Big Four accounting firms, helping to develop proprietary cost segregation software and advanced training programs. Today, Gian is a sought-after speaker who has educated thousands of CPAs and real estate professionals nationwide. In this episode, Gian and I dive into the world of cost segregation and its powerful role in boosting cash flow for real estate investors. We explore how accelerating depreciation can save investors significant money on taxes, why bonus depreciation is such a game-changer, and how even small property owners can benefit. Gian also shares insights into energy efficiency tax incentives, how technology and AI are making cost segregation more accessible, and why running real estate like a true business is the key to long-term wealth.   What You Will Learn: Who is Gian P. Pazzia, and how did he become one of the nation's leading experts in cost segregation? What exactly is cost segregation, and how can it accelerate depreciation to maximize investor cash flow? How has bonus depreciation reshaped the tax landscape for real estate owners? What practical examples show the impact of cost segregation on small and mid-size properties? How KBKG's software empowers everyday investors to take advantage of strategies once reserved for large institutional players. What energy efficiency tax incentives are available to multifamily investors and developers? Why treating real estate like a business—and leveraging the right tax strategies—is critical for building lasting wealth. Gian's story is proof that expertise, strategy, and innovation can transform the way investors approach real estate. Whether you're a new landlord with a duplex or a seasoned multifamily developer, this episode will give you practical tools to minimize taxes, maximize cash flow, and grow your portfolio more effectively.   Links & Resources: Email Address: gian.pazzia@kbkg.com Facebook: https://www.facebook.com/KBKGTaxIncentives/ X: https://twitter.com/KBKG LinkedIn: https://www.linkedin.com/company/kbkg/ Youtube: https://www.youtube.com/user/KBKGinc Discount for listeners: Use code MASSIVE2025 at checkout for 10% off KBKG's residential cost segregation software.   Attention Investors and Agents Are you looking to grow your business? Need to connect with aggressive like-minded people like yourself? We have all the right tools, knowledge, and coaching to positively effect your bottom line. Visit: Join GIA Team | The Global Investor Agent Team to see what we can offer and to schedule your FREE consultation! Our NEW book is out…order yours NOW! Global Investor Agent: How Do You Thrive Not Just Survive in a Market Shift? Get your copy here: https://amzn.to/3SV0khX   HEY! You should be in class this coming Monday (MNL). It's Free and packed with actions you should take now! Here's the link to register: https://us02web.zoom.us/webinar/register/WN_sNMjT-5DTIakCFO2ronDCg  

In this episode of the Glowing Older podcast, Nancy Griffininterviews Harry R. Moody, a distinguished professor and author, about his journey into activism in climate change, and the concept of legacy. Dr. Moody shares insights from his life, emphasizing the importance of hope, action, andintergenerational dialogue in addressing climate issues.About Dr. MoodyHarry R. Moody is a graduate of Yale University and received his Ph.D. in philosophy from Columbia University. He has taught philosophy at Columbia University, Hunter College, New York University, and the University of California at Santa Cruz.  He is the retired Vice President and Director of Academic Affairs for AARP in Washington, DC.  He is currently Visiting Professor at Tohoku University in Japan, and Distinguished Visiting Professor at Fielding Graduate University's Creativity and Wisdom Program.Dr. Moody previously served as Executive Director of theBrookdale Center on Aging at Hunter College and Chairman of the Board of Elderhostel (now Road Scholar). Moody is the author of over 100 scholarly articles, as well as a number of books including: Abundance of Life: Human Development Policies for an Aging Society (Columbia University Press, 1988) and Ethics in an Aging Society (Johns Hopkins University Press, 1992).His most recent book, Climate Change in an Aging Society,is the first book fully devoted to the impact of climate change on those who are old today―and those who will be old in decades to come. He is the editor of the Climate Change in an Aging Society and Human Values in Aging newsletters. In 2011 he received the Lifetime Achievement Award from the American Society on Aging and in 2008 he was named by Utne Reader Magazine as one of “50 Visionaries Who AreChanging Your World.”Key TakeawaysDr. Moody encourages action and hope, emphasizing that change requires collective effort.Hope is not the expectation of a better future but thebelief in doing what's right. “Hope is a verb with sleeves rolled up.” - David Orr, environmental educator and author.The concepts of aging and climate change are both perfect candidates for denial. We can overcome denial by facing up to things and doing what's possible. The “Four Horseman of the Climate Apocalypse” defined in Climate Change for an Aging Society are fire, flood, drought and heat wave.A Life Review asks, what have you done in your life isworth remembering, that is worth sharing with younger generations? Lasting change happens when generations come together. Older adults pass on their knowledge, wisdom, and experience to younger people. Theproblem with elders communicating with young people can be that elders think they know it all. Email HRMoody@yahoo.com to subscribe to the free newsletters Climate Change in an Aging Society and Human Values in Aging.

Welcome to the 10th episode of the SHE Talks podcast, presented by the Beazley SHE Network. Join our host, Gaby Martineau and special guests Stefan Versluis, Jennifer Brasfield, and Lindsay Shipper as they spotlight Elsie Eaves, a woman of many “firsts” including being the first woman admitted to full membership in the American Society of Civil Engineers.  Topics and questions discussed in this podcasts include:Elsie was all about “firsts”. She was an innovator, a pioneer, and a go-getter when it came to her career. She pivoted when things seemed less than ideal for her, and ended up really making a name for herself in the process. What message do you think young insurance professionals should take from Elsie's tale of “firsts”?Engineering was (and still is) not a very female-heavy industry. What sort of trials do you think Elsie was up against while making her way in the male dominated Engineering world?Sounds like Elsie was passionate about Engineering from a very young age. However, not everyone has that luxury. Many professionals pivot mid-career. Have any of you pivoted career-wise? If so, what's your best advice to navigate a focus shift later in your career?Support the show

Vince Beiser is an award-winning journalist and author of “The World in a Grain: The Story of Sand and How It Transformed Civilization.” The book has been translated into five languages, was a finalist for a PEN America award and a California Book Award, and spawned a TEDx talk. Vince is currently at work on a new book, “Power Metal”, about how the materials we need for digital technology and renewable energy are causing environmental havoc, political upheaval, mayhem and murder—and how we can do better.Vince has reported from over 100 countries, states, provinces, kingdoms, occupied territories, no man's lands and disaster zones. He has exposed conditions in California's harshest prisons, trained with troops bound for Iraq, ridden with the first responders to natural disasters, and hunted down other stories from around the world for publications including Wired, The Atlantic, Harper's, Time, The Guardian, Mother Jones, Playboy, Rolling Stone, The Los Angeles Times, The Wall Street Journal, and The New York Times.Vince's work has been honored by Investigative Reporters and Editors, the Society of Professional Journalists, the American Society of Journalists and Authors, the Columbia, Medill and Missouri Graduate Schools of Journalism, and many other institutions. He has three times been part of a team that won the National Magazine Award for General Excellence, and shared in an Emmy for his work with the PBS TV series SoCal Connected. He is also a grantee of the Pulitzer Center on Crisis Reporting.⁠https://vincebeiser.com/⁠⁠https://nexuspmg.com/

Given recent events, we have decided not to release a new episode this week. Instead, given rising concerns about state retribution to political violence and the weaponization of law enforcement, we are re-releasing our conversation with Lerone A. Martin from February, in which he discusses his book The Gospel of J. Edgar Hoover. _________________________________________________________ This week, Kelly and John are joined by Lerone A. Martin to discuss his unfortunately timely and prescient book, The Gospel of J. Edgar Hoover: How the FBI Aided and Abetted the Rise of White Christian Nationalism. Martin is the Martin Luther King, Jr., Centennial Professor in Religious Studies, African & African American Studies, and The Nina C. Crocker Faculty Scholar. He also serves as the Director of the Martin Luther King, Jr. Research and Education Institute at Stanford University. He's is an award-winning author. The Gospel of J. Edgar Hoover was published in February 2023 by Princeton University Press. The book has garnered praise from numerous publications including The Nation, Foreign Affairs, The Guardian, Publisher's Weekly, and History Today. In 2014 he published, Preaching on Wax: The Phonograph and the Making of Modern African American Religion. That book received the 2015 first book award by the American Society of Church History. His commentary and writing have been featured on The NBC Today Show, The History Channel, PBS, CSPAN, and NPR, as well as in The New York Times, Boston Globe, CNN.com, and the Atlanta Journal-Constitution. He currently serves as an advisor on the upcoming PBS documentary series The History of Gospel Music & Preaching.

Learn how AI is changing the EA and administrative profession – and how you can stay ahead of the curve – with expert guest Neil Malek. Recorded at EA Ignite Spring 2025 and produced by the American Society of Administrative Professionals - ASAP. Learn more and submit a listener question at asaporg.com/podcast.

Dean's Chat hosts, Drs. Jensen and Richey welcomes American Society of Podiatric Medical Assistants (ASPMA) leadership to the podcast! Join us as Tara Brown (President), Cheryl Bailey (President Elect), Michele Brandice (Immedicate Past President) discuss ASPMA as a professional organization dedicated to advancing the vital role of medical assistants in podiatric practice. This episode is proudly sponsored by Bako Diagnostics! For decades, ASPMA has served as the leading voice for podiatric medical assistants across the country, providing education, resources, and certification opportunities that strengthen both the profession and the quality of patient care. Through its mission, ASPMA is committed to elevating standards of practice, enhancing professional development, and fostering collaboration within the podiatric medical community. The society actively promotes the value of podiatric medical assistants in healthcare, ensuring they are equipped with the knowledge and skills necessary to support both practitioners and patients at the highest level. One of ASPMA's cornerstone programs is the Podiatric Medical Assistant, Certified (PMAC) credential. This certification offers assistants the opportunity to specialize in administrative, clinical, or radiology tracks, demonstrating their expertise and dedication to the profession. By supporting certification and continuing education, ASPMA not only validates the critical contributions of podiatric medical assistants but also encourages lifelong learning. In addition to certification, ASPMA provides networking opportunities, annual conferences, and ongoing educational programming. These initiatives create a strong community of podiatric medical assistants who share a commitment to excellence and professional growth. With leadership rooted in experience and passion, ASPMA continues to inspire its members to elevate their practice and strengthen the field of podiatric medicine.

Today, the microphone turns on Writers on Writing founder and host Barbara DeMarco-Barrett. She joins Marrie Stone to talk about her latest story collection, Pool Fishing. Barbara's venture into noir fiction began with the short story, “Crazy for You,” originally published in Akashic Book's, Orange County Noir, later included in USA Noir: Best of the Akashic Noir Series. She's also the editor and contributor to Palm Springs Noir (Akashic) and was nominated for a Pushcart Prize for her short story, “Rowboat,” in Kelp Journal (Dec. 2023). Both “Crazy for You” and “Rowboat” appear in her latest collection. Barbara's fiction and poetry have been published extensively, including in Coolest American Stories 2022, CrimeReads, Dark City Crime & Magazine and elsewhere. Her first book, Pen on Fire: A Busy Woman's Guide to Igniting the Writer Within, was a Los Angeles Times best-seller and honored with an American Society of Journalists and Authors Outstanding Book Award. She's taught creative writing at various colleges for decades. All that means she has much to teach us, and tell us, about the creative process. She joins Marrie to talk about the creative germ for many of these 15 stories, why setting is so critical in noir, the attributes she believes necessary to make a successful writer, why she's such an advocate for small presses, and so much more. Barbara will be appearing at Arvida Books in Tustin on Friday, September 19th, at 6pm (with Maddie Margarita) and Knoll's in Laguna Niguel on Sunday, September 21, at 7pm (with Marrie Stone). For more information, check out her website here. For more information on Writers on Writing and to become a supporter, visit our Patreon page. For a one-time donation, visit Ko-fi. You can find hundreds of past interviews on our website. You can help out the show and indie bookstores by buying books at our bookstore on bookshop.org. It's stocked with titles by our guest authors, as well as our personal favorites. And on Spotify, you'll find an album's worth of typewriter music like what you hear on the show. It's perfect for writing. Look for the artist, Just My Type. Email the show at writersonwritingpodcast@gmail.com. We love to hear from our listeners! (Recorded on September 1, 2025) Host: Barbara DeMarco-Barrett Host: Marrie Stone Music: Travis Barrett (Stream his music on Spotify, Apple Music, Etc.)

Dr. Kathleen Horst, Dr. Rachel Jimenez, and Dr. Yara Abdou discuss the updated guideline from ASTRO, ASCO, and SSO on postmastectomy radiation therapy. They share new and updated recommendations on topics including PMRT after upfront surgery, PMRT after neoadjuvant systemic therapy, dose and fractionation schedules, and delivery techniques. They comment on the importance of a multidisciplinary approach and providing personalized care based on individual patient characteristics. Finally, they review ongoing research that may impact these evidence-based guidelines in the future. Read the full guideline, “Postmastectomy Radiation Therapy: An ASTRO-ASCO-SSO Clinical Practice Guideline” at www.asco.org/breast-cancer-guidelines" TRANSCRIPT This guideline, clinical tools, and resources are available at www.asco.org/breast-cancer-guidelines. Read the full text of the guideline and review authors' disclosures of potential conflicts of interest in the Journal of Clinical Oncology, https://ascopubs.org/doi/10.1200/JCO-25-01747  Brittany Harvey: Hello and welcome to the ASCO Guidelines podcast, one of ASCO's podcasts delivering timely information to keep you up to date on the latest changes, challenges, and advances in oncology. You can find all the shows, including this one, at asco.org/podcasts. My name is Brittany Harvey, and today I am interviewing Dr. Kathleen Horst, expert panel chair from Stanford University; Dr. Rachel Jimenez, expert panel vice chair from Massachusetts General Hospital; and Dr. Yara Abdou, ASCO representative from the University of North Carolina, authors on "Postmastectomy Radiation Therapy: An American Society for Radiation Oncology, American Society of Clinical Oncology, and Society of Surgical Oncology Clinical Practice Guideline." Thank you for being here today, Dr. Horst, Dr. Jimenez, and Dr. Abdou. Dr. Kathleen Horst: Thank you for having us. Brittany Harvey: And then just before we discuss this guideline, I would like to note that ASCO takes great care in the development of its guidelines and ensuring that the ASCO conflict of interest policy is followed for each guideline. The disclosures of potential conflicts of interest for the guideline panel, including Dr. Horst, Dr. Jimenez, and Dr. Abdou who have joined us here today, are available online with the publication of the guideline in the Journal of Clinical Oncology, which is linked in the show notes. Then to dive into the content that we are here today to talk about, Dr. Horst, could you start us off by describing what prompted the update for this joint guideline between ASTRO, ASCO, and SSO, and what is the scope of this 2025 guideline on postmastectomy radiation therapy? Dr. Kathleen Horst: Thank you. This joint guideline was last updated in 2016. Over the past decade, the treatment of breast cancer has evolved substantially. Newer systemic therapy regimens have increasingly personalized treatment based on tumor biology, and local therapy management has explored both the de-escalation of axillary surgery and more abbreviated courses of radiation therapy. Given these advances, it was important to revisit the role of postmastectomy radiotherapy in this modern era of breast cancer therapy. This updated guideline addresses four key questions, including postmastectomy radiation therapy after upfront surgery as well as after neoadjuvant systemic therapy. It also reviews the evolving role of various dose and fractionation schedules and optimal treatment techniques and dose constraints. Brittany Harvey: Excellent. I appreciate that background, Dr. Horst. So then, next, Dr. Jimenez, I would like to review the recommendations of this guideline across those four key questions that Dr. Horst just mentioned. So first, what does the panel recommend for PMRT for patients who received initial treatment with mastectomy? Dr. Rachel Jimenez: The panel provided pretty strong consensus that patients with positive lymph nodes or patients with large tumors involving the skin or the chest wall should receive postmastectomy radiation. However, the panel also recognized that the omission of postmastectomy radiation may be appropriate for select patients who have positive lymph nodes and have an axillary lymph node dissection if they have a low nodal burden and other favorable clinical or pathologic features. For patients without lymph node involvement at the time of surgery and no involvement of the skin or chest wall, postmastectomy radiation was not advised by the panel. Brittany Harvey: Understood. It is helpful to understand those recommendations for that patient population. Following that, Dr. Abdou, what are the key recommendations for PMRT for patients who received neoadjuvant systemic therapy before mastectomy? Dr. Yara Abdou: When we think about PMRT after neoadjuvant treatment, the key point is that the initial stage of presentation still matters a lot. So for example, if a patient comes in with more advanced disease, say a large primary tumor, like a clinical T4, or more extensive nodal disease, like an N2 or N3 disease, those patients should get PMRT, no matter how well they respond to neoadjuvant therapy, because we know it reduces the risk of recurrence and that has been shown pretty consistently. On the other hand, if there are still positive lymph nodes after neoadjuvant treatment, basically residual nodal disease, PMRT is also strongly recommended because the risk of local-regional recurrence is much higher in that setting. The gray area is the group of patients who start with a lower burden of nodal disease, such as N1 disease, but then become node negative at surgery. For those patients, we tend to individualize the decision. So if the patient is young or has triple-negative disease, or if there is a lot of residual disease in the breast even though the nodes are cleared, then radiation is probably helpful. But if everything has melted away with pCR in both the breast and the nodes, then it may be safe to omit PMRT in those patients. For patients with smaller tumors and no nodal involvement to begin with, like a clinical T1-T2 N0, if they are still node negative after neoadjuvant treatment, then PMRT is generally not recommended because their baseline recurrence risk is low. And finally, if the margins are positive and cannot be re-excised, then PMRT is recommended after neoadjuvant therapy. Brittany Harvey: Yes, those distinctions are important for appropriate patient selection. So then, Dr. Horst, we have just reviewed the indications for PMRT, but for those patients who receive PMRT, what are the appropriate treatment volumes and dose fractionation regimens? Dr. Kathleen Horst: The guideline addresses coverage of the chest wall and regional nodes with a specific discussion of the data regarding internal mammary nodal irradiation, which has been an area of controversy over many years. The guideline also reviews the data exploring moderate hypofractionation, or shorter courses of radiation therapy. The task force recommends utilizing moderate hypofractionation for the majority of women requiring postmastectomy radiation, which is likely to have a large impact on clinical practice. This recommendation is based on the evolving data demonstrating that a 3-week course of radiotherapy after mastectomy provides similar oncologic outcomes and minimal toxicity for most patients compared to the standard 5-week treatment course. Brittany Harvey: Thank you for reviewing that set of recommendations as well. So then, Dr. Jimenez, to wrap us up on the key questions here, what delivery techniques are recommended for treating patients who receive PMRT? Dr. Rachel Jimenez: So this portion of the guideline is likely to be most helpful for radiation oncologists because it represents the most technical part of the guideline, but we do believe that it offers some important guidance that has, to this point, been lacking in the postmastectomy radiation setting. So first, the panel recommends that all patients should undergo 3-dimensional radiation planning using CAT scan based imaging, and this includes contouring. So contouring refers to the explicit identification, using a drawing interface on the CAT scan imaging, by the radiation oncologist to identify the areas that are targeted to receive radiation, as well as all of the nearby normal tissues that could receive unintended radiation exposure. And we also provide radiation oncologists in the guideline with suggestions about how much dose each target tissue should receive and what the dose limits should be for normal tissues. Additionally, we make some recommendations regarding the manner in which radiation is delivered. So for example, we advise that when conventional radiation methods are not sufficient for covering the areas of the body that are still at risk for cancer, or where too high of a dose of radiation would be anticipated to a normal part of the body, that providers employ a technique called intensity modulated radiation therapy, or IMRT. And if IMRT is going to be used, we also advise regular 3-dimensional imaging assessments of the patient's body relative to the treatment machine to ensure treatment fidelity. When the treatments are delivered, we further advise using a deep inspiration breath-hold technique, which lowers the exposure to the heart and to the lungs when there is concern for cardiopulmonary radiation exposure, and again, that image guidance be used along with real-time monitoring of the patient's anatomy when those techniques are employed. And then finally, we advise that patients receiving postmastectomy radiation utilize a bolus, or a synthetic substance placed on the patient's skin to enhance radiation dose to the superficial tissue, only when there is involvement of the skin with cancer or other high-risk features of the cancer, but not for every patient who receives postmastectomy radiation. Brittany Harvey: Understood. And then, yes, you just mentioned that section of the guideline is probably most helpful for radiation oncologists, but I think you can all comment on this next question. What should all clinicians, including radiation oncologists, surgical oncologists, medical oncologists, and other oncologic professionals, know as they implement all of these updated recommendations? Dr. Rachel Jimenez: So I think one of the things that is most important when we consider postmastectomy radiation and making recommendations is that this is a multidisciplinary panel and that we would expect and encourage our colleagues, as they interpret the guidelines, to employ a multidisciplinary approach when they are discussing each individual patient with their surgical and medical oncology colleagues, that there is no one size fits all. So these guidelines are intended to provide some general guidance around the most appropriate techniques and approaches and recommendations for the utilization of postmastectomy radiation, but that we recognize that all of these recommendations should be individualized for patients and also represent somewhat of a moving target as additional studies, both in the surgical and radiation oncology realm as well as in the systemic therapy realm, enter our milieu, we have to adjust those recommendations accordingly. Dr. Kathleen Horst: Yeah, I would agree, and I wanted to comment as a radiation oncologist, we recognize that local-regional considerations are intertwined with systemic therapy considerations. So as the data evolve, it is critical to have these ongoing updates in a cross-disciplinary manner to ensure optimal care for our patients. And as Dr. Jimenez mentioned, these multidisciplinary discussions are critical for all of us to continue to learn and understand the evolving recommendations across disciplines but also to individualize them according to individual patients. Dr. Yara Abdou: I could not agree more. I think from a medical oncology perspective, systemic therapy has gotten much better with adjuvant CDK4/6 inhibitors, T-DM1, capecitabine, and immune therapy. So these are all newer adjuvant therapies, so the baseline recurrence risks are lower than what they were in the trials that established PMRT. So the absolute benefit of radiation varies more now, so smaller for favorable biology but still relevant in aggressive subtypes or with residual disease. So it is definitely not a one-size-fits-all. Brittany Harvey: Yes, I think it is important that you have all highlighted that multidisciplinary approach and having individualized, patient-centric care. So then, expanding on that just a little bit, Dr. Abdou, how will these guideline recommendations affect patients with breast cancer? Dr. Yara Abdou: So basically, reiterating what we just talked about, these guidelines really move us towards personalized care. So for patients at higher risk, so those with larger tumors, multiple positive nodes, or residual nodal disease after neoadjuvant therapy, PMRT remains essential, consistently lowering local-regional recurrence and improving survival. But for patients at intermediate or lower risk, the recommendations support a more selective approach. So instead of a blanket rule, we now integrate tumor biology, response to systemic therapy, and individual patient factors to decide when PMRT adds meaningful benefit. So the impact for patients is really important because those at high risk continue to get the survival advantage of radiation while others can be spared the unnecessary treatment and side effects. So in short, we are aligning PMRT with modern systemic therapy and biology, making sure each patient receives the right treatment for their situation. Brittany Harvey: Absolutely. Individualizing treatment to every patient will make sure that everyone can achieve the best outcomes as possible. So then, Dr. Jimenez, to wrap us up, I believe Dr. Horst mentioned earlier that data continues to evolve in this field. So in your opinion, what are the outstanding questions regarding the use of PMRT and what are you looking to for the future of research in this space? Dr. Rachel Jimenez: So there are a number of randomized phase III clinical trials that are either in active accrual or that have reported but not yet published that are exploring further de-escalation of postmastectomy radiation and of axillary surgery. And so we do not yet have sufficient data to understand how those two pieces of information integrate with each other. So for example, if you have a patient who has a positive lymph node at the time of diagnosis and forgoes axillary surgery aside from a sentinel lymph node biopsy, we do not yet know that we can also safely forgo radiation entirely in that setting. So we expect that future studies are going to address these questions and understand when it is appropriate to simultaneously de-escalate surgery and radiation. Additionally, there is a number of trials that are looking at ways in which radiation could be omitted or shortened. So there is the RT CHARM trial, which has reported but not yet published, looking at a shorter course of radiation. And so we do make recommendations around that shorter course of radiation in this guideline, but we anticipate that the additional data from the RT CHARM study will provide further evidence in support of that. Additionally, there is a study called the TAILOR RT trial, which looks at forgoing postmastectomy radiation in patients who, to Dr. Abdou's point, have a favorable tumor biology and a low 21-gene recurrence score. And so we are going to anticipate the results from that study to help guide who can selectively forgo postmastectomy radiation when they fall into that favorable risk category. So there are a number of questions that I think will help flesh out this guideline. And as they publish, we will likely publish a focused update on that information to help provide context for our colleagues in the field and clarify some of these recommendations to suit the latest data. Brittany Harvey: Absolutely. We will look forward to those de-escalation trials and ongoing research in the field to build on the evidence and look for future updates to this guideline. So I want to thank you for your work to update these guidelines, and thank you for your time today, Dr. Horst, Dr. Jimenez, and Dr. Abdou. Dr. Rachel Jimenez: Thank you. Dr. Yara Abdou: Thank you. Dr. Kathleen Horst: Thank you. Brittany Harvey: And then finally, thank you to all of our listeners for tuning in to the ASCO Guidelines podcast. To read the full guideline, go to www.asco.org/breast-cancer-guidelines. You can also find many of our guidelines and interactive resources in the free ASCO Guidelines app, which is available in the Apple App Store or the Google Play Store. If you have enjoyed what you have heard today, please rate and review the podcast and be sure to subscribe so you never miss an episode. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.  

In this conversation, Dr. Wylin D. Wilson discusses the concept of womanist bioethics, its historical context, and the need for a more inclusive approach to bioethics that addresses the experiences of marginalized populations, particularly women of color. The discussion highlights the shortcomings of mainstream bioethics and the importance of expanding narratives to include diverse voices in healthcare and ethical considerations. In this conversation, Wylin D. Wilson and David Bryan explore the complex intersections of race, genetics, healthcare, and faith. They discuss the role of public health in addressing racism as a social determinant of health, the historical significance of the Black church in public health activism, and the broader implications of womanist bioethics. The conversation emphasizes the importance of awareness, advocacy, and the interconnectedness of all individuals in addressing health disparities and fostering community well-being.Dr. Wylin D. Wilson is Assistant Professor of Theological Ethics at Duke Divinity School, where she teaches within the Theology, Medicine and Culture Initiative.  Her teaching and research are at the intersection of Bioethics, Gender, and Theology. She is former Teaching Faculty at Harvard Medical School Center for Bioethics, she served as a Senior Fellow at the Harvard Divinity School Center for the Study of World Religions, and Visiting Lecturer in Harvard Divinity School Women's Studies in Religion Program.  She is also former Associate Director of Education for the Tuskegee University National Center for Bioethics in Research and Health Care and former faculty member of the Tuskegee University College of Agriculture, Environment and Nutrition Sciences. She is currently Principle Investigator for the Bioethics and Black Church: Addressing Racial Inequalities and Black Women's Health in North Carolina research project which examines the potential of the Black Church as a resource in addressing the Black maternal health crisis in the U.S. Dr. Wilson earned her Ph.D. in Religion, Ethics and Society from Emory University; her M.S. in Agricultural, Resource, and Managerial Economics from Cornell University; and her M.Div. from the Interdenominational Theological Center.  She is a member of the Society for the Study of Black Religion, the American Society for Bioethics and Humanities, the American Academy of Religion, and the Center for Reconciliation Advisory Board at Duke Divinity School. Dr. Wilson's publications include: “‘This is My Body': Faith Communities as Sites of Transfiguring Vulnerability” in Bioenhancement and the Vulnerable Body: A Theological Engagement (Baylor University Press, 2023); her first book, Economic Ethics and the Black Church (Palgrave Macmillan, 2017) and her second book, Womanist Bioethics: Social Justice, Spirituality and Black Women's Health (New York University Press).https://wylindwilson.com/linkedin.com/in/wylin-dassie-wilson-55bb7a47

It's time to meet the woman who set the gold standard for the role of First Lady. With her natural charm and lively spirit, Dolley Madison hosted countless gatherings for Washington's elite, turning social events into powerful political tools. Through the art of entertaining, she not only shaped the culture of the capital, but also advanced the influence and career of the nation's fourth president, James Madison. Credits: Host and Executive Producer: Sharon McMahon Supervising Producer: Melanie Buck Parks Audio Producer: Craig Thompson To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

Have you heard about people buying weight loss medications from unregulated sources online? The rise of black market weight loss drugs is putting lives at risk. In this episode, I discuss the concerning trend of people purchasing Retatrutide—a medication still in clinical trials—through illegal channels. Known as the "Godzilla Jab" for its potential power, early studies suggest this drug could help people lose up to 24% of their body weight. I explain what Retatrutide is and how it compares to FDA-approved medications like Ozempic, Wegovy, Zepbound, and Mounjaro. We explore why people take dangerous risks with black market drugs, from social media hype to cost concerns and access issues. Most importantly, I share the serious health and legal risks of buying unregulated medications and provide clear guidelines for safely accessing weight loss treatments through licensed providers. Tune in to learn how to protect yourself and make informed decisions about weight loss medications the safe way.   Episode Highlights: What is Retatrutide The dangers of purchasing unregulated medications online Factors driving people to illegal sources Legal risks of buying unapproved drugs and potential health complications from unregulated substances Safe Medication Practices Understanding that medication works best when combined with healthy eating, physical activity, adequate rest, and emotional support   Connect with Dr. Alicia Shelly: Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd   About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH.  Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014.  In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss,  where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, “Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''.   Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)

Dr. Chad Miller from Colorado State University shares his innovative approach to teaching horticulture through a classroom trade show format that transforms traditional plant identification courses into engaging, multidimensional learning experiences. As the 2024 ASHS Outstanding Undergraduate Educator award winner, he discusses how he combines plant knowledge with professional skill development to prepare students for success beyond the classroom.• Creating a trade show environment where students showcase plant knowledge creatively• Moving beyond memorization to develop professional communication skills• Using peer evaluation to help students learn to give and receive constructive feedback• Approaching teaching as scholarship worthy of research and publication• Balancing high expectations with understanding of students' complex lives• Finding joy in seeing students succeed professionally• Establishing a classroom culture where it's safe to not know and to learn from mistakesTo read more about Dr. Miller's teaching approach, check out his award-winning paper "Classroom Trade Show: An Alternative to Traditional Classroom Presentations in an Undergraduate Plant Identification Course" in HortTechnology. If you're interested in teaching innovations in horticulture, consider joining the ASHS Teaching Methods Interest Group.Learn more about the American Society for Horticultural Science (ASHS) at https://ashs.org/.HortTechnology, HortScience and the Journal of the American Society for Horticultural Science are all open-access and peer-reviewed journals, published by the American Society of Horticultural Science (ASHS). Find them at journals.ashs.org.Consider becoming an ASHS member at https://ashs.org/page/Becomeamember!You can also find the official webpage for Plants, People, Science at ashs.org/plantspeoplesciencepodcast, and we encourage you to send us feedback or suggestions at https://ashs.org/webinarpodcastsuggestion. Podcast transcripts are available at https://plantspeoplescience.buzzsprout.com.On LinkedIn find Sam Humphrey at linkedin.com/in/samson-humphrey. Curt Rom is at https://www.linkedin.com/in/curt-rom-611085134/. Lena Wilson is at https://www.linkedin.com/in/lena-wilson-2531a5141/. Thank you for listening! ...

In this episode of the DermSurgery Digest, you'll hear a summary of the surgical oncology and reconstruction articles in the September 2025 issue of Dermatologic Surgery followed by commentary from special guest contributors Mark Russell, MD, and Ami Greene, MD. This podcast is hosted by Dermatologic Surgery Digital Content Editor, Naomi Lawrence, MD, and co-hosted by Michael Renzi, MD. Dermatologic Surgery is the official publication of the American Society for Dermatologic Surgery. In this podcast series the cosmetic and general dermatology articles in the September issue of Dermatologic Surgery are featured in a separate episode. Your feedback is encouraged. Please contact communicationstaff@asds.net.

So I had the chance to sit down with Elesha Coffman, who's written what might be the only book entirely devoted to the Christian Century magazine, and we ended up diving deep into the whole messy question of what "mainline Protestantism" even means - which apparently stumped two past presidents of the American Society of Church History during her dissertation defense, with the best answer being something about railroads in Philadelphia. We talked through her journey from Christianity Today to studying the Christian Century, how these magazines both spoke to and sometimes wildly misjudged their audiences (especially around Billy Graham), and the cultural capital that tied together mainline Protestant clergy even when their theology and politics diverged from their congregations. What struck me was how the isolation of educated clergy - whether it's the 1920s pastor in North Dakota parceling out his weekly dose of seminary culture through the Christian Century, or today's mainline clergy feeling lonely in their own congregations - keeps showing up as this recurring theme in American church history. Plus, she's working on a book about the Religion News Service, which was apparently run by Jewish editors providing church news to Christian newspapers. This goes to show how much more complicated and interesting these stories get when you actually dig into the archives. Elesha Coffman is a historian of American Christianity and professor of history at Baylor University. She is the author of The Christian Century and the Rise of the Protestant Mainline and Turning Points in American Church History, as well as a biography of anthropologist Margaret Mead. UPCOMING ONLINE CLASS - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The God of Justice: Where Ancient Wisdom Meets Contemporary Longing⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ This transformative online class brings together distinguished scholars from biblical studies, theology, history, and faith leadership to offer exactly what our moment demands: the rich, textured wisdom of multiple academic disciplines speaking into our contemporary quest for justice. Here you'll discover how ancient texts illuminate modern struggles, how theological reflection deepens social action, and how historical understanding opens new possibilities for faithful engagement with our world's brokenness and beauty. Join John Dominic Crossan, Peter Enns, Casey Sigmon, Aizaiah Yong, & Malcolm Foley As always, the class is donation-based, including 0. INFO & Sign-Up at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.FaithAndPolitics.net⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Theology Beer Camp ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠is a unique three-day conference that brings together of theology nerds and craft beer for a blend of intellectual engagement, community building, and fun. Guests this year include John Dominic Crossan, Kelly Brown Douglas, Philip Clayton, Stacey Floyd-Thomas, Jeffery Pugh, Juan Floyd-Thomas, Andy Root, Grace Ji-Sun Kim, Noreen Herzfeld, Reggie Williams, Casper ter Kuile, and more! ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Get info and tickets here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. _____________________ This podcast is a ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Homebrewed Christianity⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ production. Follow ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠the Homebrewed Christianity⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Theology Nerd Throwdown⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, & ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The Rise of Bonhoeffer⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ podcasts for more theological goodness for your earbuds. Join over 75,000 other people by joining our⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Substack - Process This!⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Get instant access to over 50 classes at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.TheologyClass.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Follow the podcast, drop a review⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, send ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠feedback/questions⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ or become a ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠member of the HBC Community⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Learn more about your ad choices. Visit megaphone.fm/adchoices

Are you an EA or administrative professional who works with a Board of Directors? Want to sharpen your skills? Learn from expert Carissa Burgett. Recorded at EA Ignite Spring 2025 and produced by the American Society of Administrative Professionals - ASAP. Learn more and submit a listener question at asaporg.com/podcast.

Check out my top picks for skin care here. Download the Free eBook 'Skincare Myths Busted' What do you do when the face in the mirror doesn't match how you feel inside? Welcome to the skin shift that happens in midlife — a direct result of hormonal changes, specifically the drop in estrogen that comes with perimenopause and menopause. And while it's common, it's not talked about enough. Until now. In this episode, I sit down with Dr. Pooja Rambhia, a board-certified dermatologist who's leading the conversation around what's been coined the “menopause makeover.” This is about understanding what's happening in your skin and body during menopause, and how to support both with science, compassion, and the right strategies. From collagen loss to skin laxity to the real reason your products aren't working anymore, we cover it all. We also talk about realistic solutions, from injectables and resurfacing lasers to hormone therapy and everyday skincare that actually supports your skin at this stage of life. This episode is not about “fixing” your face. It's about finally getting answers to the questions so many women are asking and doing so with a sense of clarity. Key Takeaways: Skin loses up to 30% of its collagen in the first five years after menopause. Estrogen is important for your skin's hydration, elasticity, thickness, and glow. It's normal to experience acne, dryness, sagging, and texture changes but that doesn't mean you have to just accept it. Bio-stimulatory injectables, topical actives, laser treatments, and even hormone replacement therapy can all play a role when used wisely and intentionally. Aging is not a decline. It's a transition that deserves support, not shame. Pooja H. Rambhia, MD, is a board-certified dermatologist with specialized fellowship training in cosmetic dermatology and laser surgery. She practices at UnionDerm in New York City and Greenwich, CT, providing comprehensive dermatologic care and specializing in laser treatments, injectables, and facial and body contouring for all skin types. Dr. Rambhia completed her medical training at Case Western Reserve University and dermatology residency at Zucker School of Medicine/Northwell Health, where she served as Chief Resident. She then completed the prestigious American Society for Dermatologic Surgery Fellowship at UnionDerm with Dr. Anne Chapas. Committed to advancing the field of dermatology, Dr. Rambhia has published numerous peer-reviewed articles in leading journals and presented her research at major national conferences including the American Academy of Dermatology and the American Society for Dermatologic Surgery. Her expertise has been featured in major media outlets including Vogue, Allure, Marie Claire, InStyle, Elle and The New York Times. Dr. Rambhia is dedicated to delivering personalized, natural-looking results while combining artistry with the latest scientific innovations in aesthetic dermatology. Follow Dr. Rambhia here: https://www.instagram.com/drpoojarambhia/?hl=en https://www.instagram.com/unionderm/?hl=en https://www.unionderm.com/ Download my Free Guide 'In My Perimenopause Era'

We're told vitamins are essential for our health. That they boost our immune systems, fight fatigue, and protect us from disease. But what if most of it isn't true? In the 20th century, vitamin supplements were hailed as a breakthrough, curing diseases like scurvy and rickets. But that success story took a turn. In the US, a law passed in 1994 — helped by a Hollywood ad campaign — removed almost all oversight from the supplement industry. Since then, a $40 billion business has grown in the shadows. One where marketing beats science, and health claims are made with barely any evidence. Dr. David Seres is Director of Medical Nutrition and a Professor at Columbia University's Institute of Human Nutrition. David is known for calling out pseudoscience and misinformation, and promoting critical thinking and an evidence-based approach to health. For over 25 years, he's worked as a physician nutrition specialist, caring for critically ill patients who rely on life-saving nutrition support. He received the Excellence in Nutrition Education Award from the American Society for Nutrition. On this episode, he helps us debunk the vitamin supplement industry. Unwrap the truth about your food

Breaking down examples of why American society is broken. Ilhan Omar suddenly is worth as much as $30 million. How could that possibly happen? Johnny Heidt with guitar news. HEARD ON THE SHOW:Walz says he plans to call special session on gun laws in wake of Annunciation shootingMan who threatened to ‘shoot up' UnitedHealth campus found incompetent; State still intends to prosecutePowerball jackpot rises to an estimated $1.3 billion after no winning ticket soldSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.